Document:

Exhibit 10.15 

[FORM OF SERIES E
WARRANT] 

NEITHER THE ISSUANCE AND SALE OF
THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE
SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE,
SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN
OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. 

AMISH NATURALS, INC.  

WARRANT TO PURCHASE
COMMON STOCK  

Warrant No.:              
 Number of
Shares of Common Stock: 
Date of Issuance:  February [__], 2008 ("Issuance Date") 

        Amish
Naturals, Inc., a Nevada corporation, (the “Company”), hereby certifies
that, for good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, CASTLERIGG MASTER INVESTMENTS LTD., the registered holder hereof or its
permitted assigns (the “Holder”), is entitled, subject to the terms set
forth below, to purchase from the Company, at the Exercise Price (as defined below) then
in effect, upon surrender of this Warrant to Purchase Common Stock (including any Warrants
to purchase Common Stock issued in exchange, transfer or replacement hereof, the
“Warrant”), at any time or times on or after the date hereof, but not
after 11:59 p.m., New York Time, on the Expiration Date (as defined below), 5,000,000
fully paid nonassessable shares of Common Stock (as defined below) (the
“Warrant Shares”). Except as otherwise defined herein, capitalized terms
in this Warrant shall have the meanings set forth in Section 15. This Warrant is one of
the Warrants to purchase Common Stock (the “SPA Warrants”) issued
pursuant to Section 1 of that certain Securities Purchase Agreement, dated as of February
20, 2008 (the “Subscription Date”), by and among the Company and the
investors (the “Buyers”) referred to therein (the “Securities
Purchase Agreement”). 

	 	1. 	EXERCISE
OF WARRANT.  

    
          
          (a)           Mechanics
of Exercise. Subject to the terms and conditions hereof           (including, without
limitation, the limitations set forth in Section 1(f)), this           Warrant may be
exercised by the Holder on any day on or after the date hereof in           whole or in
part, by (i) delivery of a written notice, in the form attached           hereto as
Exhibit A (the “Exercise Notice”), of the           Holder’s
election to exercise this Warrant and (ii) (A) payment to the           Company of
an amount equal to the applicable Exercise Price multiplied by the           number of
Warrant Shares as to which this Warrant is being exercised (the           “Aggregate
Exercise Price”) in cash or by wire transfer of           immediately available
funds or (B) by notifying the Company that this Warrant is           being exercised
pursuant to a Cashless Exercise (as defined in Section 1(d)).           The Holder shall
not be required to deliver the original Warrant in order to           effect an exercise
hereunder. Execution and delivery of the Exercise Notice with           respect to less
than all of the Warrant Shares shall have the same effect as           cancellation of
the original Warrant and issuance of a new Warrant evidencing           the right to
purchase the remaining number of Warrant Shares. On or before the           first
Business Day following the date on which the Company has received each of           the
Exercise Notice and the Aggregate Exercise Price (or notice of a Cashless
          Exercise) (the “Exercise Delivery Documents”), the Company
          shall transmit by facsimile an acknowledgment of confirmation of receipt of the
          Exercise Delivery Documents to the Holder and the Company’s transfer agent
          (the “Transfer Agent”). On or before the third Trading Day
          following the date on which the Company has received all of the Exercise
          Delivery Documents (the “Share Delivery Date”), the Company
          shall (X) provided that the Transfer Agent is participating in The Depository
          Trust Company (“DTC”) Fast Automated Securities Transfer
          Program, upon the request of the Holder, credit such aggregate number of shares
          of Common Stock to which the Holder is entitled pursuant to such exercise to
the           Holder’s or its designee’s balance account with DTC through its
          Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not
          participating in the DTC Fast Automated Securities Transfer Program, issue and
          dispatch by overnight courier to the address as specified in the Exercise
          Notice, a certificate, registered in the Company’s share register in the
          name of the Holder or its designee, for the number of shares of Common Stock to
          which the Holder is entitled pursuant to such exercise. Upon delivery of the
          Exercise Delivery Documents, the Holder shall be deemed for all corporate
          purposes to have become the holder of record of the Warrant Shares with respect
          to which this Warrant has been exercised, irrespective of the date such Warrant
          Shares are credited to the Holder’s DTC account or the date of delivery of
          the certificates evidencing such Warrant Shares, as the case may be. If this
          Warrant is submitted in connection with any exercise pursuant to this Section
          1(a) and the number of Warrant Shares represented by this Warrant submitted for
          exercise is greater than the number of Warrant Shares being acquired upon an
          exercise, then the Company shall as soon as practicable and in no event later
          than three Business Days after any exercise and at its own expense, issue a new
          Warrant (in accordance with Section 7(d)) representing the right to purchase
the           number of Warrant Shares purchasable immediately prior to such exercise
under           this Warrant, less the number of Warrant Shares with respect to which
this           Warrant is exercised. No fractional shares of Common Stock are to be
issued upon           the exercise of this Warrant, but rather the number of shares of
Common Stock to           be issued shall be rounded up to the nearest whole number. The
Company shall pay           any and all taxes which may be payable with respect to the
issuance and delivery           of Warrant Shares upon exercise of this Warrant.  

2 

    
          
          (b)           Exercise
Price. For purposes of this Warrant, “Exercise           Price” means
$1.1056, subject to adjustment as provided           herein.  

    
          
          (c)           Company’s
Failure to Timely Deliver Securities. If the Company shall           fail for any
reason or for no reason to issue to the Holder within three (3)           Trading Days of
receipt of the Exercise Delivery Documents, a certificate for           the number of
shares of Common Stock to which the Holder is entitled and           register such shares
of Common Stock on the Company’s share register or to           credit the Holder’s
balance account with DTC for such number of shares of           Common Stock to which the
Holder is entitled upon the Holder’s exercise of           this Warrant, then, in
addition to all other remedies available to the Holder,           the Company shall pay
in cash to the Holder on each day after such thirdTrading Day that the issuance of
such shares of Common Stock is not timely           effected an amount equal to 1.5% of
the product of (A) the sum of the number of           shares of Common Stock not issued
to the Holder on a timely basis and to which           the Holder is entitled and (B) the
Closing Sale Price of the shares of Common           Stock on the Trading Day immediately
preceding the last possible date which the           Company could have issued such
shares of Common Stock to the Holder without           violating Section 1(a). In
addition to the foregoing, if within three (3)           Trading Days after the Company’s
receipt of the facsimile copy of a           Exercise Notice the Company shall fail to
issue and deliver a certificate to the           Holder and register such shares of
Common Stock on the Company’s share           register or credit the Holder’s
balance account with DTC for the number of           shares of Common Stock to which the
Holder is entitled upon the Holder’s           exercise hereunder, and if on or
after such Trading Day the Holder purchases (in           an open market transaction or
otherwise) shares of Common Stock to deliver in           satisfaction of a sale by the
Holder of shares of Common Stock issuable upon           such exercise that the Holder
anticipated receiving from the Company (a           “Buy-In”), then the
Company shall, within three Business Days           after the Holder’s request and
in the Holder’s discretion, either (i)           pay cash to the Holder in an amount
equal to the Holder’s total purchase           price (including brokerage
commissions, if any) for the shares of Common Stock           so purchased (the “Buy-In
Price”), at which point the           Company’s obligation to deliver such
certificate (and to issue such shares           of Common Stock) or credit such Holder’s
balance account with DTC shall           terminate, or (ii) promptly honor its obligation
to deliver to the Holder a           certificate or certificates representing such shares
of Common Stock or credit           such Holder’s balance account with DTC and pay
cash to the Holder in an           amount equal to the excess (if any) of the Buy-In
Price over the product of (A)           such number of shares of Common Stock, times (B)
the Closing Bid Price on the           date of exercise.  

		    
          
          (d)           Cashless
Exercise. Notwithstanding anything contained herein to the           contrary, if a
Registration Statement (as defined in the Registration Rights           Agreement)
covering the resale of the Warrant Shares that are the subject of the           Exercise
Notice (the “Unavailable Warrant Shares”) is not           available for
the resale of such Unavailable Warrant Shares, the Holder may, in           its sole
discretion, exercise this Warrant in whole or in part and, in lieu of           making
the cash payment otherwise contemplated to be made to the Company upon           such
exercise in payment of the Aggregate Exercise Price, elect instead to           receive
upon such exercise the “Net Number” of shares of Common Stock
          determined according to the following formula (a “Cashless
          Exercise”):  

3 

			
	Net Number =
	(A x B) - (A x C)

B 
	

        For
purposes of the foregoing formula: 

        A=
the total number of shares with respect to which this Warrant is then being exercised. 

        B= the
Closing Sale Price of the shares of Common Stock (as reported by Bloomberg) on the date
immediately preceding the date of the Exercise Notice. 

        C=
the Exercise Price then in effect for the applicable Warrant Shares at the time of such
exercise. 

    
          
          (e)        Disputes.
In the case of a dispute as to the determination of the                     Exercise
Price or the arithmetic calculation of the Warrant Shares, the Company
                    shall promptly issue to the Holder the number of Warrant Shares that
are not                     disputed and resolve such dispute in accordance with Section
12.  

    
          
          (f)        Limitations
on Exercises.  

		    (i)               Beneficial
Ownership. The Company shall not effect the exercise of this
                    Warrant, and the Holder shall not have the right to exercise this
Warrant, to                     the extent that after giving effect to such exercise,
such Person (together with                     such Person’s affiliates) would
beneficially own in excess of 4.99% (the                     “Maximum Percentage”)
of the shares of Common Stock outstanding                     immediately after giving
effect to such exercise. For purposes of the foregoing                     sentence, the
aggregate number of shares of Common Stock beneficially owned by                     such
Person and its affiliates shall include the number of shares of Common
                    Stock issuable upon exercise of this Warrant with respect to which
the                     determination of such sentence is being made, but shall exclude
shares of Common                     Stock which would be issuable upon (A) exercise of
the remaining, unexercised                     portion of this Warrant beneficially owned
by such Person and its affiliates and                     (B) exercise or conversion of
the unexercised or unconverted portion of any                     other securities of the
Company beneficially owned by such Person and its                     affiliates
(including, without limitation, any convertible notes or convertible
                    preferred stock or warrants) subject to a limitation on conversion or
exercise                     analogous to the limitation contained herein. Except as set
forth in the                     preceding sentence, for purposes of this paragraph,
beneficial ownership shall                     be calculated in accordance with Section
13(d) of the Securities Exchange Act of                     1934, as amended (the “Exchange
Act”). For purposes of this                     Warrant, in determining the
number of outstanding shares of Common Stock, the                     Holder may rely on
the number of outstanding shares of Common Stock as reflected                     in (1)
the Company’s most recent Form 10-K, Form 10-KSB, Form 10-Q, Form
                    10-QSB, Current  

4 

		Report on
Form 8-K or other public filing with the Securities and Exchange Commission, as the case
may be, (2) a more recent public announcement by the Company or (3) any other notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock
outstanding. For any reason at any time, upon the written or oral request of the Holder,
the Company shall within one (1) Business Day confirm orally and in writing to the Holder
the number of shares of Common Stock then outstanding. In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including the SPA Securities and the
SPA Warrants, by the Holder and its affiliates since the date as of which such number of
outstanding shares of Common Stock was reported. By written notice to the Company, the
Holder may from time to time increase or decrease the Maximum Percentage to any other
percentage not in excess of 9.99% specified in such notice; provided that (i) any such
increase will not be effective until the sixty-first (61st) day after such
notice is delivered to the Company, and (ii) any such increase or decrease will apply
only to the Holder and not to any other holder of SPA Warrants. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict
conformity with the terms of this Section 1(f) to correct this paragraph (or any portion
hereof) which may be defective or inconsistent with the intended beneficial ownership
limitation herein contained or to make changes or supplements necessary or desirable to
properly give effect to such limitation.  

		    (ii)        Principal
Market Regulation. The Company shall not be obligated to issue
                    any shares of Common Stock upon exercise of this Warrant or
conversion of SPA                     Securities and no Buyer shall be entitled to
receive any shares of Common Stock                     if the issuance of such shares of
Common Stock would exceed that number of                     shares of Common Stock which
the Company may issue upon exercise or conversion,                     as applicable, of
the SPA Warrants and SPA Securities or otherwise without                     breaching
the Company’s obligations under the rules or regulations of any
                    applicable Eligible Market (the “Exchange Cap”),
except that                     such limitation shall not apply in the event that the
Company (A) obtains the                     approval of its shareholders as required by
the applicable rules of the Eligible                     Market for issuances of shares
of Common Stock in excess of such amount or (B)                     obtains a written
opinion from outside counsel to the Company that such approval                     is not
required, which opinion shall be reasonably satisfactory to the Required
                    Holders. Until such approval or written opinion is obtained, no Buyer
shall be                     issued in the aggregate, upon exercise or conversion, as
applicable, of any SPA                     Warrants or SPA Securities, shares of Common
Stock in an amount greater than the                     product of the Exchange Cap
multiplied by a fraction, the numerator of which is                     the total number
of shares of Common Stock underlying the SPA Warrants issued to                     such
Buyer pursuant to the Securities Purchase Agreement on the Issuance Date
                    and the denominator of which is the aggregate number of shares of
Common Stock                     underlying the SPA Warrants issued to the Buyers
pursuant to the Securities                     Purchase Agreement on the Issuance Date
(with respect to each Buyer, the                     “Exchange Cap Allocation”).
In the event that any Buyer shall                     sell or otherwise transfer any of
such Buyer’s SPA Warrants, the transferee                     shall be allocated a
pro rata portion of such Buyer’s Exchange Cap                     Allocation, and
the restrictions of the prior sentence shall apply to such                     transferee
with respect to the portion of the Exchange Cap Allocation allocated
                    to such transferee. In the event that any holder of SPA Warrants
shall exercise                     all of such holder’s SPA Warrants into a number
of shares of Common Stock                     which, in the aggregate, is less than such
holder’s Exchange Cap                     Allocation, then the difference between
such holder’s Exchange Cap                     Allocation and the number of shares
of Common Stock actually issued to such                     holder shall be allocated to
the respective Exchange Cap Allocations of the                     remaining holders of
SPA Warrants on a pro rata basis in proportion to the                     shares of
Common Stock underlying the SPA Warrants then held by each such
                    holder. In the event that the Company is prohibited from issuing any
Warrant                     Shares for which an Exercise Notice has been received as a
result of the                     operation of this Section 1(f)(ii), the Company shall
pay cash in exchange for                     cancellation of such Warrant Shares, at a
price per Warrant Share equal to the                     difference between the Closing
Sale Price and the Exercise Price as of the date                     of the attempted
exercise.  

5 

    
          
          (g)           Insufficient
Authorized Shares. If at any time while this Warrant remain           outstanding the
Company does not have a sufficient number of authorized and           unreserved shares
of Common Stock to satisfy its obligation to reserve for           issuance upon exercise
of this Warrant at least a number of shares of Common           Stock equal to 130% (the
“Required Reserve Amount”) of the           number of shares of Common
Stock as shall from time to time be necessary to           effect the exercise of all of
this Warrant then outstanding (an           “Authorized Share Failure”),
then the Company shall immediately           take all action necessary to increase the
Company’s authorized shares of           Common Stock to an amount sufficient to
allow the Company to reserve the           Required Reserve Amount for this Warrant then
outstanding. Without limiting the           generality of the foregoing sentence, as soon
as practicable after the date of           the occurrence of an Authorized Share Failure,
but in no event later than ninety           (90) days after the occurrence of such
Authorized Share Failure, the Company           shall hold a meeting of its stockholders
for the approval of an increase in the           number of authorized shares of Common
Stock. In connection with such meeting,           the Company shall provide each
stockholder with a proxy statement and shall use           its best efforts to solicit
its stockholders’ approval of such increase in           authorized shares of Common
Stock and to cause its board of directors to           recommend to the stockholders that
they approve such proposal.  

6 

	 	2.  	ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise
                    Price and the number of Warrant Shares shall be adjusted from time to
time as                     follows:  

    
          
          (a)        Adjustment
upon Issuance of shares of Common Stock. If and whenever on or
                    after the Subscription Date the Company issues or sells, or in
accordance with                     this Section 2 is deemed to have issued or sold, any
shares of Common Stock                     (including the issuance or sale of shares of
Common Stock owned or held by or                     for the account of the Company, but
excluding shares of Common Stock deemed to                     have been issued by the
Company in connection with any Excluded Securities) for                     a
consideration per share (the “New Issuance Price”) less than
                    the Exercise Price (the “Applicable Price”) in
effect                     immediately prior to such issue or sale or deemed issuance or
sale (the                     foregoing a “Dilutive Issuance”), then
immediately after such                     Dilutive Issuance, the Exercise Price then in
effect shall be reduced to an                     amount equal to the New Issuance Price.
Upon each such adjustment of the                     Exercise Price hereunder, the number
of Warrant Shares shall be adjusted to the                     number of shares of Common
Stock determined by multiplying the Exercise Price in                     effect
immediately prior to such adjustment by the number of Warrant Shares
                    acquirable upon exercise of this Warrant immediately prior to such
adjustment                     and dividing the product thereof by the Exercise Price
resulting from such                     adjustment. For purposes of determining the
adjusted Exercise Price under this                     Section 2(a), the following shall
be applicable:  

		    (i)        Issuance
of Options. If the Company in any manner grants any Options and
                    the lowest price per share for which one share of Common Stock is
issuable upon                     the exercise of any such Option or upon conversion,
exercise or exchange of any                     Convertible Securities issuable upon
exercise of any such Option is less than                     the Applicable Price, then
such share of Common Stock shall be deemed to be                     outstanding and to
have been issued and sold by the Company at the time of the                     granting
or sale of such Option for such price per share. For purposes of this
                    Section 2(a)(i), the “lowest price per share for which one share
of Common                     Stock is issuable upon exercise of such Options or upon
conversion, exercise or                     exchange of such Convertible Securities
issuable upon exercise of any such                     Option” shall be equal to the
sum of the lowest amounts of consideration                     (if any) received or
receivable by the Company with respect to any one share of                     Common
Stock upon the granting or sale of the Option, upon exercise of the
                    Option and upon conversion, exercise or exchange of any Convertible
Security                     issuable upon exercise of such Option. No further adjustment
of the Exercise                     Price or number of Warrant Shares shall be made upon
the actual issuance of such                     shares of Common Stock or of such
Convertible Securities upon the exercise of                     such Options or upon the
actual issuance of such shares of Common Stock upon                     conversion,
exercise or exchange of such Convertible Securities.  

7 

		    (ii)        Issuance
of Convertible Securities. If the Company in any manner issues                     or
sells any Convertible Securities and the lowest price per share for which one
                    share of Common Stock is issuable upon the conversion, exercise or
exchange                     thereof is less than the Applicable Price, then such share
of Common Stock shall                     be deemed to be outstanding and to have been
issued and sold by the Company at                     the time of the issuance or sale of
such Convertible Securities for such price                     per share. For the
purposes of this Section 2(a)(ii), the “lowest price per                     share
for which one share of Common Stock is issuable upon the conversion,
                    exercise or exchange thereof” shall be equal to the sum of the
lowest                     amounts of consideration (if any) received or receivable by
the Company with                     respect to one share of Common Stock upon the
issuance or sale of the                     Convertible Security and upon conversion,
exercise or exchange of such                     Convertible Security. No further
adjustment of the Exercise Price or number of                     Warrant Shares shall be
made upon the actual issuance of such shares of Common                     Stock upon
conversion, exercise or exchange of such Convertible Securities, and
                    if any such issue or sale of such Convertible Securities is made upon
exercise                     of any Options for which adjustment of this Warrant has been
or is to be made                     pursuant to other provisions of this Section 2(a),
no further adjustment of the                     Exercise Price or number of Warrant
Shares shall be made by reason of such issue                     or sale.  

		    (iii)        Change
in Option Price or Rate of Conversion. If the purchase price
                    provided for in any Options, the additional consideration, if any,
payable upon                     the issue, conversion, exercise or exchange of any
Convertible Securities, or                     the rate at which any Convertible
Securities are convertible into or exercisable                     or exchangeable for
shares of Common Stock increases or decreases at any time,                     the
Exercise Price and the number of Warrant Shares in effect at the time of
                    such increase or decrease shall be adjusted to the Exercise Price and
the number                     of Warrant Shares which would have been in effect at such
time had such Options                     or Convertible Securities provided for such
increased or decreased purchase                     price, additional consideration or
increased or decreased conversion rate, as                     the case may be, at the
time initially granted, issued or sold. For purposes of                     this Section
2(a)(iii), if the terms of any Option or Convertible Security that
                    was outstanding as of the date of issuance of this Warrant are
increased or                     decreased in the manner described in the immediately
preceding sentence, then                     such Option or Convertible Security and the
shares of Common Stock deemed                     issuable upon exercise, conversion or
exchange thereof shall be deemed to have                     been issued as of the date
of such increase or decrease. No adjustment pursuant                     to this Section
2(a)(iii) shall be made if such adjustment would result in an
                    increase of the Exercise Price then in effect or a decrease in the
number of                     Warrant Shares.  

8 

		    (iv)        Calculation
of Consideration Received. In case any Option is issued in
                    connection with the issue or sale of other securities of the Company,
together                     comprising one integrated transaction in which no specific
consideration is                     allocated to such Options by the parties thereto,
the Options will be deemed to                     have been issued for a consideration of
$0.01. If any shares of Common Stock,                     Options or Convertible
Securities are issued or sold or deemed to have been                     issued or sold
for cash, the consideration received therefor will be deemed to                     be
the net amount received by the Company therefor. If any shares of Common
                    Stock, Options or Convertible Securities are issued or sold for a
consideration                     other than cash, the amount of such consideration
received by the Company will                     be the fair value of such consideration,
except where such consideration                     consists of publicly traded
securities, in which case the amount of                     consideration received by the
Company will be the Closing Sale Price of such                     security on the date
of receipt. If any shares of Common Stock, Options or                     Convertible
Securities are issued to the owners of the non-surviving entity in
                    connection with any merger in which the Company is the surviving
entity, the                     amount of consideration therefor will be deemed to be the
fair value of such                     portion of the net assets and business of the
non-surviving entity as is                     attributable to such shares of Common
Stock, Options or Convertible Securities,                     as the case may be. The
fair value of any consideration other than cash or                     publicly traded
securities will be determined jointly by the Company and the                     Required
Holders. If such parties are unable to reach agreement within ten (10)
                    days after the occurrence of an event requiring valuation (the
                    “Valuation Event”), the fair value of such
consideration will                     be determined within five (5) Business Days after
the tenth day following the                     Valuation Event by an independent,
reputable appraiser jointly selected by the                     Company and the Required
Holders. The determination of such appraiser shall be                     final and
binding upon all parties absent manifest error and the fees and
                    expenses of such appraiser shall be borne by the Company.  

		    (v)        Record
Date. If the Company takes a record of the holders of shares of
                    Common Stock for the purpose of entitling them (A) to receive a
dividend or                     other distribution payable in shares of Common Stock,
Options or in Convertible                     Securities or (B) to subscribe for or
purchase shares of Common Stock,                     Options or Convertible Securities,
then such record date will be deemed to be                     the date of the issue or
sale of the shares of Common Stock deemed to have been                     issued or sold
upon the declaration of such dividend or the making of such other
                    distribution or the date of the granting of such right of
subscription or                     purchase, as the case may be.  

		    (vi)        Voluntary
Adjustment By Company. The Company may at any time during the
                    term of this Warrant reduce the then current  Exercise
                    Price to any amount and for any period of time deemed
appropriate by the                     Board of Directors of the Company.  

9 

		    (vii)        Automatic
Adjustment. On each of November [__], 2008 and August [__],                     2009
(each, an “Adjustment  Date”), if 75% of the Average
                    Market Price (as defined in the SPA Securities) is less than the then
existing                     Exercise Price, the then current Exercise Price hereunder
shall be reset to 75%                     of the Average Market Price (as defined in the
SPA Securities) as of the                     applicable Adjustment Date; provided, in no
event shall such reset result in an                     increase in the then existing
Exercise Price.  

		    (viii)        Milestone
Adjustment. If the Company fails any Financial Milestone (as
                    defined in the SPA Securities) (each a “Milestone Failure”)
the                     then current Exercise Price hereunder shall be reset on the tenth
(10th) Trading                     Date after the earlier to occur of the applicable
Announcement Date (as defined                     in the SPA Securities) or Announcement
Date Deadline (as defined in the SPA                     Securities) to 75% of the
Average Market Price as of the date that is ten (10)                     Trading Days
after such Announcement Date or Announcement Date Deadline, as
                    applicable; provided, in no event shall such reset result in an
increase in the                     then existing Exercise Price.  

    
          
          (b)        Adjustment
upon Subdivision or Combination of shares of Common Stock. If                     the
Company at any time on or after the Subscription Date subdivides (by any
                    stock split, stock dividend, recapitalization or otherwise) one or
more classes                     of its outstanding shares of Common Stock into a greater
number of shares, the                     Exercise Price in effect immediately prior to
such subdivision will be                     proportionately reduced and the number of
Warrant Shares will be proportionately                     increased. If the Company at
any time on or after the Subscription Date combines                     (by combination,
reverse stock split or otherwise) one or more classes of its
                    outstanding shares of Common Stock into a smaller number of shares,
the Exercise                     Price in effect immediately prior to such combination
will be proportionately                     increased and the number of Warrant Shares
will be proportionately decreased.                     Any adjustment under this Section
2(b) shall become effective at the close of                     business on the date the
subdivision or combination becomes effective.  

    
          
          (c)        Other
Events. If any event occurs of the type contemplated by the
                    provisions of this Section 2 but not expressly provided for by such
provisions                     (including, without limitation, the granting of stock
appreciation rights,                     phantom stock rights or other rights with equity
features), then the                     Company’s Board of Directors will make an
appropriate adjustment in the                     Exercise Price and the number of
Warrant Shares so as to protect the rights of                     the Holder; provided
that no such adjustment pursuant to this Section 2(c) will                     increase
the Exercise Price or decrease the number of Warrant Shares as
                    otherwise determined pursuant to this Section 2.  

10 

    3.           RIGHTS
UPON DISTRIBUTION OF ASSETS. If the Company shall declare or make           any
dividend or other distribution of its assets (or rights to acquire its           assets)
to holders of shares of Common Stock, by way of return of capital or           otherwise
(including, without limitation, any distribution of cash, stock or           other
securities, property or options by way of a dividend, spin off,
          reclassification, corporate rearrangement, scheme of arrangement or other
          similar transaction) (a “Distribution”), at any time after the
          issuance of this Warrant, then, in each such case:  

    
          
          (a)                     any
Exercise Price in effect immediately prior to the close of business on the
          record date fixed for the determination of holders of shares of Common Stock
          entitled to receive the Distribution shall be reduced, effective as of the
close           of business on such record date, to a price determined by multiplying
such           Exercise Price by a fraction of which (i) the numerator shall be the
Closing Bid           Price of the shares of Common Stock on the Trading Day immediately
preceding           such record date minus the value of the Distribution (as determined
in good           faith by the Company’s Board of Directors) applicable to one share
of           Common Stock, and (ii) the denominator shall be the Closing Bid Price of the
          shares of Common Stock on the Trading Day immediately preceding such record
          date; and  

    
          
          (b)                     the
number of Warrant Shares shall be increased to a number of shares equal to           the
number of shares of Common Stock obtainable immediately prior to the close           of
business on the record date fixed for the determination of holders of shares           of
Common Stock entitled to receive the Distribution multiplied by the           reciprocal
of the fraction set forth in the immediately preceding paragraph (a);           provided
that in the event that the Distribution is of shares of common stock           (“Other
Shares of Common Stock”) of a company whose common           shares are traded
on a national securities exchange or a national automated           quotation system,
then the Holder may elect to receive a warrant to purchase           Other Shares of
Common Stock in lieu of an increase in the number of Warrant           Shares, the terms
of which shall be identical to those of this Warrant, except           that such warrant
shall be exercisable into the number of shares of Other Shares           of Common Stock
that would have been payable to the Holder pursuant to the           Distribution had the
Holder exercised this Warrant immediately prior to such           record date and with an
aggregate exercise price equal to the product of the           amount by which the
exercise price of this Warrant was decreased with respect to           the Distribution
pursuant to the terms of the immediately preceding paragraph           (a) and the number
of Warrant Shares calculated in accordance with the first           part of this
paragraph (b).  

    4.           PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS.  

    
          
          (a)           Purchase
Rights. In addition to any adjustments pursuant to Section 2           above, if at
any time the Company grants, issues or sells any Options,           Convertible
Securities or rights to purchase stock, warrants, securities or           other property
pro rata to the record holders of any class of shares of Common           Stock (the
“Purchase Rights”), then the Holder will be entitled           to
acquire, upon the terms applicable to such Purchase Rights, the aggregate
          Purchase Rights which the Holder could have acquired if the Holder had held the
          number of shares of Common Stock acquirable upon complete exercise of this
          Warrant (without regard to any limitations on the exercise of this Warrant)
          immediately before the date on which a record is taken for the grant, issuance
          or sale of such Purchase Rights, or, if no such record is taken, the date as of
          which the record holders of shares of Common Stock are to be determined for the
          grant, issue or sale of such Purchase Rights.  

11 

    
          
          (b)           Fundamental
Transactions. The Company shall not enter into or be party to           a Fundamental
Transaction unless (i)  the Successor Entity assumes in           writing all of the
obligations of the Company under this Warrant and the other           Transaction
Documents in accordance with the provisions of this Section (4)(b)           pursuant to
written agreements in form and substance satisfactory to the           Required Holders
and approved by the Required Holders prior to such Fundamental           Transaction,
including agreements to deliver to each holder of Warrants in           exchange for such
Warrants a security of the Successor Entity evidenced by a           written instrument
substantially similar in form and substance to this Warrant,           including, without
limitation, an adjusted exercise price equal to the value for           the shares of
Common Stock reflected by the terms of such Fundamental           Transaction, and
exercisable for a corresponding number of shares of capital           stock equivalent to
the shares of Common Stock acquirable and receivable upon           exercise of this
Warrant (without regard to any limitations on the exercise of           this Warrant)
prior to such Fundamental Transaction, and satisfactory to the           Required Holders
and (ii) the Successor Entity (including its Parent           Entity) is a publicly
traded corporation whose common stock is quoted on or           listed for trading on an
Eligible Market. Upon the occurrence of any Fundamental           Transaction, the
Successor Entity shall succeed to, and be substituted for (so           that from and
after the date of such Fundamental Transaction, the provisions of           this Warrant
referring to the “Company” shall refer instead to the           Successor
Entity), and may exercise every right and power of the Company and           shall assume
all of the obligations of the Company under this Warrant with the           same effect
as if such Successor Entity had been named as the Company herein.           Upon
consummation of the Fundamental Transaction, the Successor Entity shall           deliver
to the Holder confirmation that there shall be issued upon exercise of           this
Warrant at any time after the consummation of the Fundamental Transaction,           in
lieu of the shares of the Common Stock (or other securities, cash, assets or
          other property) purchasable upon the exercise of the Warrant prior to such
          Fundamental Transaction, such shares of the publicly traded Common Stock (or
its           equivalent) of the Successor Entity (including its Parent Entity) which the
          Holder would have been entitled to receive upon the happening of such
          Fundamental Transaction had this Warrant been converted immediately prior to
          such Fundamental Transaction, as adjusted in accordance with the provisions of
          this Warrant. In addition to and not in substitution for any other rights
          hereunder, prior to the consummation of any Fundamental Transaction pursuant to
          which holders of shares of Common Stock are entitled to receive securities or
          other assets with respect to or in exchange for shares of Common Stock (a
          “Corporate Event”), the Company shall make appropriate
          provision to insure that the Holder will thereafter have the right to receive
          upon an exercise of this Warrant at any time after the consummation of the
          Fundamental Transaction but prior to the Expiration Date, in lieu of the shares
          of the Common Stock (or other securities, cash, assets or other property)
          purchasable upon the exercise of the Warrant prior to such Fundamental
          Transaction, such shares of stock, securities, cash, assets or any other
          property whatsoever (including warrants or other purchase or subscription
          rights) which the Holder would have been entitled to receive upon the happening
          of such Fundamental Transaction had the Warrant been exercised immediately
prior           to such Fundamental Transaction. Provision made pursuant to the preceding
          sentence shall be in a form and substance reasonably satisfactory to the
          Required Holders. The provisions of this Section shall apply similarly and
          equally to successive Fundamental Transactions and Corporate Events and shall
be           applied without regard to any limitations on the exercise of this Warrant.  

12 

    
          
          (c)                     Notwithstanding
the foregoing and the provisions of Section 4(b) above, in the           event of a
Fundamental Transaction, at the request of the Holder delivered           before the
ninetieth (90th) day after the consummation of such Fundamental           Transaction,
the Company (or the Successor Entity) shall purchase this Warrant           from the
Holder by paying to the Holder, within five (5) Business Days of such           request
(or, if later, on the effective date of the Fundamental Transaction,           cash in an
amount equal to the Black-Scholes Value of the remaining unexercised           portion of
this Warrant on the date of such Fundamental Transaction.  

13 

    5.           WARRANT
HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically           provided
herein, the Holder, solely in such Person’s capacity as a holder           of this
Warrant, shall not be entitled to vote or receive dividends or be deemed           the
holder of share capital of the Company for any purpose, nor shall anything
          contained in this Warrant be construed to confer upon the Holder, solely in
such           Person’s capacity as the Holder of this Warrant, any of the rights of
a           shareholder of the Company or any right to vote, give or withhold consent to
any           corporate action (whether any reorganization, issue of stock,
reclassification           of stock, consolidation, merger, conveyance or otherwise),
receive notice of           meetings, receive dividends or subscription rights, or
otherwise, prior to the           issuance to the Holder of the Warrant Shares which such
Person is then entitled           to receive upon the due exercise of this Warrant. In
addition, nothing contained           in this Warrant shall be construed as imposing any
liabilities on the Holder to           purchase any securities (upon exercise of this
Warrant or otherwise) or as a           shareholder of the Company, whether such
liabilities are asserted by the Company           or by creditors of the Company.
Notwithstanding this Section 5, the Company           shall provide the Holder with
copies of the same notices and other information           given to the shareholders of
the Company generally, contemporaneously with the           giving thereof to the
shareholders.  

    6.           NONCIRCUMVENTION.
The Company hereby covenants and agrees that the           Company will not, by amendment
of its Articles of Incorporation, Bylaws or           through any reorganization,
transfer of assets, consolidation, merger, scheme of           arrangement, dissolution,
issue or sale of securities, or any other voluntary           action, avoid or seek to
avoid the observance or performance of any of the terms           of this Warrant, and
will at all times in good faith carry out all the           provisions of this Warrant
and take all action as may be required to protect the           rights of the Holder.
Without limiting the generality of the foregoing, the           Company (i) shall
not increase the par value of any shares of Common Stock           receivable upon the
exercise of this Warrant above the Exercise Price then in           effect, (ii) shall
take all such actions as may be necessary or appropriate           in order that the
Company may validly and legally issue fully paid and           nonassessable shares of
Common Stock upon the exercise of this Warrant, and           (iii) shall, so long as any
of the SPA Warrants are outstanding, take all action           necessary to reserve and
keep available out of its authorized and unissued           shares of Common Stock,
solely for the purpose of effecting the exercise of the           SPA Warrants, 130% of
the number of shares of Common Stock as shall from time to           time be necessary to
effect the exercise of the SPA Warrants then outstanding           (without regard to any
limitations on exercise).  

    7.           REISSUANCE
OF WARRANTS.  

    
          
          (a)           Transfer
of Warrant. If this Warrant is to be transferred, the Holder           shall
surrender this Warrant to the Company, whereupon the Company will           forthwith
issue and deliver upon the order of the Holder a new Warrant (in           accordance
with Section 7(d)), registered as the Holder may request,           representing the
right to purchase the number of Warrant Shares being           transferred by the Holder
and, if less than the total number of Warrant Shares           then underlying this
Warrant is being transferred, a new Warrant (in accordance           with Section 7(d))
to the Holder representing the right to purchase the number           of Warrant Shares
not being transferred.  

14 

    
          
          (b)           Lost,
Stolen or Mutilated Warrant. Upon receipt by the Company of           evidence
reasonably satisfactory to the Company of the loss, theft, destruction           or
mutilation of this Warrant, and, in the case of loss, theft or destruction,           of
any indemnification undertaking by the Holder to the Company in customary           form
and, in the case of mutilation, upon surrender and cancellation of this
          Warrant, the Company shall execute and deliver to the Holder a new Warrant (in
          accordance with Section 7(d)) representing the right to purchase the Warrant
          Shares then underlying this Warrant.  

    
          
          (c)           Exchangeable
for Multiple Warrants. This Warrant is exchangeable, upon           the surrender
hereof by the Holder at the principal office of the Company, for a           new Warrant
or Warrants (in accordance with Section 7(d)) representing in the           aggregate the
right to purchase the number of Warrant Shares then underlying           this Warrant,
and each such new Warrant will represent the right to purchase           such portion of
such Warrant Shares as is designated by the Holder at the time           of such
surrender; provided, however, that no Warrants for fractional shares of           Common
Stock shall be given.  

    
          
          (d)           Issuance
of New Warrants. Whenever the Company is required to issue a new           Warrant
pursuant to the terms of this Warrant, such new Warrant (i) shall be of           like
tenor with this Warrant, (ii) shall represent, as indicated on the face of           such
new Warrant, the right to purchase the Warrant Shares then underlying this
          Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a)
          or Section 7(c), the Warrant Shares designated by the Holder which, when added
          to the number of shares of Common Stock underlying the other new Warrants
issued           in connection with such issuance, does not exceed the number of Warrant
Shares           then underlying this Warrant), (iii) shall have an issuance date, as
indicated           on the face of such new Warrant which is the same as the Issuance
Date, and (iv)           shall have the same rights and conditions as this Warrant.  

    8.           NOTICES.
Whenever notice is required to be given under this Warrant,           unless otherwise
provided herein, such notice shall be given in accordance with           Section 9(f) of
the Securities Purchase Agreement. The Company shall provide the           Holder with
prompt written notice of all actions taken pursuant to this Warrant,           including
in reasonable detail a description of such action and the reason           therefore.
Without limiting the generality of the foregoing, the Company will           give written
notice to the Holder (i) immediately upon any adjustment of the           Exercise Price,
setting forth in reasonable detail, and certifying, the           calculation of such
adjustment and (ii) at least fifteen days prior to the date           on which the
Company closes its books or takes a record (A) with respect to any           dividend or
distribution upon the shares of Common Stock, (B) with respect to           any grants,
issuances or sales of any Options, Convertible Securities or rights           to purchase
stock, warrants, securities or other property to holders of shares           of Common
Stock or (C) for determining rights to vote with respect to any           Fundamental
Transaction, dissolution or liquidation, provided in each case that           such
information shall be made known to the public prior to or in conjunction           with
such notice being provided to the Holder.  

    9.           AMENDMENT
AND WAIVER. Except as otherwise provided herein, the provisions           of this
Warrant may be amended and the Company may take any action herein           prohibited,
or omit to perform any act herein required to be performed by it,           only if the
Company has obtained the written consent of the Required Holders;           provided that
no such action may increase the exercise price of any SPA Warrant           or decrease
the number of shares or class of stock obtainable upon exercise of           any SPA
Warrant without the written consent of the Holder. No such amendment           shall be
effective to the extent that it applies to less than all of the holders           of the
SPA Warrants then outstanding.  

15 

    10.           GOVERNING
LAW. This Warrant shall be governed by and construed and           enforced in
accordance with, and all questions concerning the construction,           validity,
interpretation and performance of this Warrant shall be governed by,           the
internal laws of the State of New York, without giving effect to any choice           of
law or conflict of law provision or rule (whether of the State of New York or
          any other jurisdictions) that would cause the application of the laws of any
          jurisdictions other than the State of New York.  

    11.           CONSTRUCTION;
HEADINGS. This Warrant shall be deemed to be jointly           drafted by the Company
and all the Buyers and shall not be construed against any           person as the drafter
hereof. The headings of this Warrant are for convenience           of reference and shall
not form part of, or affect the interpretation of, this           Warrant.  

    12.           DISPUTE
RESOLUTION. In the case of a dispute as to the determination of           the
Exercise Price or the arithmetic calculation of the Warrant Shares, the           Company
shall submit the disputed determinations or arithmetic calculations via
          facsimile within two Business Days of receipt of the Exercise Notice giving
rise           to such dispute, as the case may be, to the Holder. If the Holder and the
          Company are unable to agree upon such determination or calculation of the
          Exercise Price or the Warrant Shares within three Business Days of such
disputed           determination or arithmetic calculation being submitted to the Holder,
then the           Company shall, within two Business Days submit via facsimile (a) the
disputed           determination of the Exercise Price to an independent, reputable
investment bank           selected by the Company and approved by the Holder or (b) the
disputed           arithmetic calculation of the Warrant Shares to the Company’s
independent,           outside accountant. The Company shall cause at its expense the
investment bank           or the accountant, as the case may be, to perform the
determinations or           calculations and notify the Company and the Holder of the
results no later than           ten Business Days from the time it receives the disputed
determinations or           calculations. Such investment bank’s or accountant’s
determination or           calculation, as the case may be, shall be binding upon all
parties absent           demonstrable error.  

    13.           REMEDIES,
OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies           provided in
this Warrant shall be cumulative and in addition to all other           remedies
available under this Warrant and the other Transaction Documents, at           law or in
equity (including a decree of specific performance and/or other           injunctive
relief), and nothing herein shall limit the right of the Holder right           to pursue
actual damages for any failure by the Company to comply with the terms           of this
Warrant. The Company acknowledges that a breach by it of its obligations
          hereunder will cause irreparable harm to the Holder and that the remedy at law
          for any such breach may be inadequate. The Company therefore agrees that, in
the           event of any such breach or threatened breach, the holder of this Warrant
shall           be entitled, in addition to all other available remedies, to an
injunction           restraining any breach, without the necessity of showing economic
loss and           without any bond or other security being required.  

16 

    14.           TRANSFER.
This Warrant may be offered for sale, sold, transferred or           assigned without the
consent of the Company, except as may otherwise be required           by Section 2(g) of
the Securities Purchase Agreement.  

    15.           SEVERABILITY.
If any provision of this Agreement is prohibited by law or           otherwise determined
to be invalid or unenforceable by a court of competent           jurisdiction, the
provision that would otherwise be prohibited, invalid or           unenforceable shall be
deemed amended to apply to the broadest extent that it           would be valid and
enforceable, and the invalidity or unenforceability of such           provision shall not
affect the validity of the remaining provisions of this           Agreement so long as
this Agreement as so modified continues to express, without           material change,
the original intentions of the parties as to the subject matter           hereof and the
prohibited nature, invalidity or unenforceability of the           provision(s) in
question does not substantially impair the respective           expectations or
reciprocal obligations of the parties or the practical           realization of the
benefits that would otherwise be conferred upon the parties.           The parties will
endeavor in good faith negotiations to replace the prohibited,           invalid or
unenforceable provision(s) with a valid provision(s), the effect of           which comes
as close as possible to that of the prohibited, invalid or           unenforceable
provision(s).  

    16.           CERTAIN
DEFINITIONS. For purposes of this Warrant, the following terms           shall have
the following meanings:  

    
          
          (a)           Approved
Stock Plan” means any employee benefit plan which has been           approved by
the Board of Directors of the Company, pursuant to which the           Company’s
securities may be issued to any employee, consultant, officer or           director for
services provided to the Company.  

    
          
          (b)                     “Black
Scholes Value” means the value of this Warrant based on           the Black and
Scholes Option Pricing Model obtained from the “OV”          function on
Bloomberg determined as of the day of closing of the applicable           Fundamental
Transaction for pricing purposes and reflecting (i) a risk-free           interest rate
corresponding to the U.S. Treasury rate for a period equal to the           remaining
term of this Warrant as of such date of request, (ii) an expected           volatility
equal to the greater of 100% and the 100 day volatility obtained from           the HVT
function on Bloomberg as of the day immediately following the public
          announcement of the applicable Fundamental Transaction and (iii) the underlying
          price per share used in such calculation shall be the sum of the price per
share           being offered in cash, if any, plus the value of any non cash
consideration, if           any, being offered in the Fundamental Transaction.  

    
          
          (c)                     “Bloomberg” means
Bloomberg Financial Markets.  

    
          
          (d)                     “Business
Day” means any day other than Saturday, Sunday or           other day on which
commercial banks in The City of New York are authorized or           required by law to
remain closed.  

17 

    
          
          (e)                     “Closing
Bid Price” and “Closing Sale Price”          means, for any
security as of any date, the last closing bid price and last           closing trade
price, respectively, for such security on the Principal Market, as           reported by
Bloomberg, or, if the Principal Market begins to operate on an           extended hours
basis and does not designate the closing bid price or the closing           trade price,
as the case may be, then the last bid price or last trade price,           respectively,
of such security prior to 4:00:00 p.m., New York Time, as reported           by
Bloomberg, or, if the Principal Market is not the principal securities           exchange
or trading market for such security, the last closing bid price or last           trade
price, respectively, of such security on the principal securities exchange           or
trading market where such security is listed or traded as reported by
          Bloomberg, or if the foregoing do not apply, the last closing bid price or last
          trade price, respectively, of such security in the over-the-counter market on
          the electronic bulletin board for such security as reported by Bloomberg, or,
if           no closing bid price or last trade price, respectively, is reported for such
          security by Bloomberg, the average of the bid prices, or the ask prices,
          respectively, of any market makers for such security as reported in the
          “pink sheets” by Pink Sheets LLC (formerly the National Quotation
          Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price cannot be
          calculated for a security on a particular date on any of the foregoing bases,
          the Closing Bid Price or the Closing Sale Price, as the case may be, of such
          security on such date shall be the fair market value as mutually determined by
          the Company and the Holder. If the Company and the Holder are unable to agree
          upon the fair market value of such security, then such dispute shall be
resolved           pursuant to Section 12. All such determinations to be appropriately
adjusted for           any stock dividend, stock split, stock combination or other
similar transaction           during the applicable calculation period.  

    
          
          (f)                     “Common
Stock” means (i) the Company’s shares of           Common Stock, par
value $0.001 per share, and (ii) any share capital into           which such Common
Stock shall have been changed or any share capital resulting           from a
reclassification of such Common Stock.  

    
          
          (g)                     “Convertible
Securities” means any stock or securities (other           than Options)
directly or indirectly convertible into or exercisable or           exchangeable for
shares of Common Stock.  

    
          
          (h)                     “Eligible
Market” means the Principal Market, the American           Stock Exchange, The
New York Stock Exchange, Inc., The NASDAQ Global Market, The           NASDAQ Capital
Market or The NASDAQ Global Select Market.  

    
          
          (i)                     “Excluded
Securities” means any Common Stock issued or           issuable: (i) in
connection with any Approved Stock Plan; (ii) upon conversion           of the SPA
Securities or the exercise of the SPA Warrants; (iii) in connection           with the
payment of any Interest Shares on the SPA Securities; and (iv) upon           exercise of
any Options or Convertible Securities which are outstanding on the           day
immediately preceding the Subscription Date, provided that the terms of such
          Options or Convertible Securities are not amended, modified or changed on or
          after the Subscription Date.  

    
          
          (j)                     “Expiration
Date” means seven (7) years after the Issuance           Date, but if such date
falls on a day other than a Business Day or on which           trading does not take
place on the Principal market (a           “Holiday”), the next day that
is not a Holiday.  

18 

    
          
          (k)                     “Fundamental
Transaction” means that the Company shall directly           or indirectly, in
one or more related transactions, (i) consolidate or merge           with or into
(whether or not the Company is the surviving corporation) another           Person, or
(ii) sell, assign, transfer, convey or otherwise dispose of all or
          substantially all of the properties or assets of the Company to another Person,
          or (iii) allow another Person to make a purchase, tender or exchange offer that
          is accepted by the holders of more than the 50% of either the outstanding
shares           of Common Stock (not including any shares of Common Stock held by the
Person or           Persons making or party to, or associated or affiliated with the
Persons making           or party to, such purchase, tender or exchange offer), or (iv)
consummate a           stock purchase agreement or other business combination (including,
without           limitation, a reorganization, recapitalization, spin-off or scheme of
          arrangement) with another Person whereby such other Person acquires more than
          the 50% of the outstanding shares of Common Stock (not including any shares of
          Common Stock held by the other Person or other Persons making or party to, or
          associated or affiliated with the other Persons making or party to, such stock
          purchase agreement or other business combination), or (v) reorganize,
          recapitalize or reclassify its Common Stock, or (vi) any “person” or
          “group” (as these terms are used for purposes of Sections 13(d) and
          14(d) of the Exchange Act), become the “beneficial owner” (as defined
          in Rule 13d-3 under the Exchange Act), directly or indirectly, of 50% of the
          aggregate ordinary voting power represented by issued and outstanding Common
          Stock.  

    
          
          (l)                     “Options” means
any rights, warrants or options to subscribe           for or purchase shares of Common
Stock or Convertible Securities.  

    
          
          (m)                     “Parent
Entity” of a Person means an entity that, directly or           indirectly,
controls the applicable Person and whose common stock or equivalent           equity
security is quoted or listed on an Eligible Market, or, if there is more           than
one such Person or Parent Entity, the Person or Parent Entity with the           largest
public market capitalization as of the date of consummation of the           Fundamental
Transaction.  

    
          
          (n)                     “Person” means
an individual, a limited liability company, a           partnership, a joint venture, a
corporation, a trust, an unincorporated           organization, any other entity and a
government or any department or agency           thereof.  

    
          
          (o)                     “Principal
Market” means the OTC Bulletin Board.  

    
          
          (p)                     “Registration
Rights Agreement” means that certain Registration           Rights Agreement
dated as of the Issuance Date by and among the Company and the           Buyers.  

    
          
          (q)                     “Required
Holders” means the holders of the SPA Warrants           representing at least a
majority of shares of Common Stock underlying the SPA           Warrants then
outstanding.  

    
          
          (r)                     “SPA
Securities” means the Notes issued pursuant to the           Securities Purchase
Agreement.  

    
          
          (s)                     “Successor
Entity” means the Person (or, if so elected by the           Required Holders,
the Parent Entity) formed by, resulting from or surviving any           Fundamental
Transaction or the Person (or, if so elected by the Required           Holders, the
Parent Entity) with which such Fundamental Transaction shall have           been entered
into.  

19 

    
          
          (t)                     “Trading
Day” means any day on which the Common Stock is traded           on the
Principal Market, or, if the Principal Market is not the principal           trading
market for the Common Stock, then on the principal securities exchange           or
securities market on which the Common Stock is then traded; provided that           “Trading
Day” shall not include any day on which the Common Stock is           scheduled to
trade on such exchange or market for less than 4.5 hours or any day           that the
Common Stock is suspended from trading during the final hour of trading           on such
exchange or market (or if such exchange or market does not designate in           advance
the closing time of trading on such exchange or market, then during the           hour
ending at 4:00:00 p.m., New York Time).  

    
          
          (u)                     “Weighted
Average Price” means, for any security as of any           date, the dollar
volume-weighted average price for such security on the           Principal Market during
the period beginning at 9:30:01 a.m., New York Time (or           such other time as the
Principal Market publicly announces is the official open           of trading), and
ending at 4:00:00 p.m., New York Time (or such other time as           the Principal
Market publicly announces is the official close of trading) as           reported by
Bloomberg through its “Volume at Price” functions, or, if           the
foregoing does not apply, the dollar volume-weighted average price of such
          security in the over-the-counter market on the electronic bulletin board for
          such security during the period beginning at 9:30:01 a.m., New York Time (or
          such other time as such market publicly announces is the official open of
          trading), and ending at 4:00:00 p.m., New York Time (or such other time as such
          market publicly announces is the official close of trading) as reported by
          Bloomberg, or, if no dollar volume-weighted average price is reported for such
          security by Bloomberg for such hours, the average of the highest closing bid
          price and the lowest closing ask price of any of the market makers for such
          security as reported in the “pink sheets” by Pink Sheets LLC
(formerly           the National Quotation Bureau, Inc.). If the Weighted Average Price
cannot be           calculated for a security on a particular date on any of the
foregoing bases,           the Weighted Average Price of such security on such date shall
be the fair           market value as mutually determined by the Company and the Holder.
If the           Company and the Holder are unable to agree upon the fair market value of
such           security, then such dispute shall be resolved pursuant to Section 12. All
such           determinations are to be appropriately adjusted for any stock dividend,
stock           split, stock combination or other similar transaction during the
applicable           calculation period.  

[Signature Page
Follows] 

20 

        IN
WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to be
duly executed as of the Issuance Date set out above. 

		
		AMISH NATURALS, INC.

By:                 

Name:

Title:

21 

EXHIBIT A 

EXERCISE NOTICE 

TO BE EXECUTED BY THE
REGISTERED HOLDER TO EXERCISE THIS 
WARRANT TO PURCHASE
COMMON STOCK 

AMISH NATURALS, INC. 

        The
undersigned holder hereby exercises the right to purchase _________________ of the shares
of Common Stock (“Warrant Shares”) of Amish Naturals, Inc., a Nevada
corporation (the “Company”), evidenced by the attached Warrant to
Purchase Common Stock (the “Warrant”). Capitalized terms used herein and
not otherwise defined shall have the respective meanings set forth in the Warrant. 

         1.       
          Form of Exercise Price. The Holder intends that payment of the Exercise Price
          shall be made as: 

					
		____________
	
a "Cash Exercise" with respect to

Warrant Shares; and/or
	____________ 	

					
		____________
	
a "Cashless Exercise" with respect to

    Warrant Shares.

	____________ 	

         2.       
          Payment of Exercise Price. In the event that the holder has elected a Cash
          Exercise with respect to some or all of the Warrant Shares to be issued pursuant
          hereto, the holder shall pay the Aggregate Exercise Price in the sum of
          $___________________ to the Company in accordance with the terms of the Warrant. 

         3.       
          Delivery of Warrant Shares. The Company shall deliver to the holder __________
          Warrant Shares in accordance with the terms of the Warrant. 

Date: _______________ __, ______ 

___________________________
Name of Registered Holder 

By: ___________________________

                                                 
Name: ___________________________

Title:___________________________ 

ACKNOWLEDGMENT 

        The
Company hereby acknowledges this Exercise Notice and hereby directs American Stock
Transfer & Trust Company to issue the above indicated number of shares of
Common Stock in accordance with the Transfer Agent Instructions dated February [__], 2008
from the Company and acknowledged and agreed to by American Stock Transfer & Trust
Company. 

		
		AMISH NATURALS, INC.

By:__________________________ 

         Name:

         Title:

[FORM OF SERIES F
WARRANT] 

NEITHER THE ISSUANCE AND SALE OF
THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE
SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE,
SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN
OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. 

AMISH NATURALS, INC.  

SERIES F WARRANT TO PURCHASE
COMMON STOCK  

Warrant No.:              
 Number of
Shares of Common Stock: 
Date of Issuance:  February [__], 2008 ("Issuance Date") 

        Amish
Naturals, Inc., a Nevada corporation, (the “Company”), hereby certifies
that, for good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, CASTLERIGG MASTER INVESTMENTS LTD., the registered holder hereof or its
permitted assigns (the “Holder”), is entitled, subject to the terms set
forth below, to purchase from the Company, at the Exercise Price (as defined below) then
in effect, upon surrender of this Warrant to Purchase Common Stock (including any Warrants
to purchase Common Stock issued in exchange, transfer or replacement hereof, the
“Warrant”), at any time or times on or after the date hereof, but not
after 11:59 p.m., New York Time, on the Expiration Date (as defined below), 2,500,000
fully paid nonassessable shares of Common Stock (as defined below) (the
“Warrant Shares”). Except as otherwise defined herein, capitalized terms
in this Warrant shall have the meanings set forth in Section 15. This Warrant is one of
the Warrants to purchase Common Stock (the “SPA Warrants”) issued
pursuant to Section 1 of that certain Securities Purchase Agreement, dated as of February
20, 2008 (the “Subscription Date”), by and among the Company and the
investors (the “Buyers”) referred to therein (the “Securities
Purchase Agreement”). 

	 	1. 	EXERCISE
OF WARRANT.  

    
          
          (a)           Mechanics
of Exercise. Subject to the terms and conditions hereof           (including, without
limitation, the limitations set forth in Section 1(f)), this           Warrant may be
exercised by the Holder on any day on or after the date hereof in           whole or in
part, by (i) delivery of a written notice, in the form attached           hereto as
Exhibit A (the “Exercise Notice”), of the           Holder’s
election to exercise this Warrant and (ii) (A) payment to the           Company of
an amount equal to the applicable Exercise Price multiplied by the           number of
Warrant Shares as to which this Warrant is being exercised (the           “Aggregate
Exercise Price”) in cash or by wire transfer of           immediately available
funds or (B) by notifying the Company that this Warrant is           being exercised
pursuant to a Cashless Exercise (as defined in Section 1(d)).           The Holder shall
not be required to deliver the original Warrant in order to           effect an exercise
hereunder. Execution and delivery of the Exercise Notice with           respect to less
than all of the Warrant Shares shall have the same effect as           cancellation of
the original Warrant and issuance of a new Warrant evidencing           the right to
purchase the remaining number of Warrant Shares. On or before the           first
Business Day following the date on which the Company has received each of           the
Exercise Notice and the Aggregate Exercise Price (or notice of a Cashless
          Exercise) (the “Exercise Delivery Documents”), the Company
          shall transmit by facsimile an acknowledgment of confirmation of receipt of the
          Exercise Delivery Documents to the Holder and the Company’s transfer agent
          (the “Transfer Agent”). On or before the third Trading Day
          following the date on which the Company has received all of the Exercise
          Delivery Documents (the “Share Delivery Date”), the Company
          shall (X) provided that the Transfer Agent is participating in The Depository
          Trust Company (“DTC”) Fast Automated Securities Transfer
          Program, upon the request of the Holder, credit such aggregate number of shares
          of Common Stock to which the Holder is entitled pursuant to such exercise to
the           Holder’s or its designee’s balance account with DTC through its
          Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not
          participating in the DTC Fast Automated Securities Transfer Program, issue and
          dispatch by overnight courier to the address as specified in the Exercise
          Notice, a certificate, registered in the Company’s share register in the
          name of the Holder or its designee, for the number of shares of Common Stock to
          which the Holder is entitled pursuant to such exercise. Upon delivery of the
          Exercise Delivery Documents, the Holder shall be deemed for all corporate
          purposes to have become the holder of record of the Warrant Shares with respect
          to which this Warrant has been exercised, irrespective of the date such Warrant
          Shares are credited to the Holder’s DTC account or the date of delivery of
          the certificates evidencing such Warrant Shares, as the case may be. If this
          Warrant is submitted in connection with any exercise pursuant to this Section
          1(a) and the number of Warrant Shares represented by this Warrant submitted for
          exercise is greater than the number of Warrant Shares being acquired upon an
          exercise, then the Company shall as soon as practicable and in no event later
          than three Business Days after any exercise and at its own expense, issue a new
          Warrant (in accordance with Section 7(d)) representing the right to purchase
the           number of Warrant Shares purchasable immediately prior to such exercise
under           this Warrant, less the number of Warrant Shares with respect to which
this           Warrant is exercised. No fractional shares of Common Stock are to be
issued upon           the exercise of this Warrant, but rather the number of shares of
Common Stock to           be issued shall be rounded up to the nearest whole number. The
Company shall pay           any and all taxes which may be payable with respect to the
issuance and delivery           of Warrant Shares upon exercise of this Warrant.  

2 

    
          
          (b)           Exercise
Price. For purposes of this Warrant, “Exercise           Price” means
$0.001, subject to adjustment as provided           herein.  

    
          
          (c)           Company’s
Failure to Timely Deliver Securities. If the Company shall           fail for any
reason or for no reason to issue to the Holder within three (3)           Trading Days of
receipt of the Exercise Delivery Documents, a certificate for           the number of
shares of Common Stock to which the Holder is entitled and           register such shares
of Common Stock on the Company’s share register or to           credit the Holder’s
balance account with DTC for such number of shares of           Common Stock to which the
Holder is entitled upon the Holder’s exercise of           this Warrant, then, in
addition to all other remedies available to the Holder,           the Company shall pay
in cash to the Holder on each day after such thirdTrading Day that the issuance of
such shares of Common Stock is not timely           effected an amount equal to 1.5% of
the product of (A) the sum of the number of           shares of Common Stock not issued
to the Holder on a timely basis and to which           the Holder is entitled and (B) the
Closing Sale Price of the shares of Common           Stock on the Trading Day immediately
preceding the last possible date which the           Company could have issued such
shares of Common Stock to the Holder without           violating Section 1(a). In
addition to the foregoing, if within three (3)           Trading Days after the Company’s
receipt of the facsimile copy of a           Exercise Notice the Company shall fail to
issue and deliver a certificate to the           Holder and register such shares of
Common Stock on the Company’s share           register or credit the Holder’s
balance account with DTC for the number of           shares of Common Stock to which the
Holder is entitled upon the Holder’s           exercise hereunder, and if on or
after such Trading Day the Holder purchases (in           an open market transaction or
otherwise) shares of Common Stock to deliver in           satisfaction of a sale by the
Holder of shares of Common Stock issuable upon           such exercise that the Holder
anticipated receiving from the Company (a           “Buy-In”), then the
Company shall, within three Business Days           after the Holder’s request and
in the Holder’s discretion, either (i)           pay cash to the Holder in an amount
equal to the Holder’s total purchase           price (including brokerage
commissions, if any) for the shares of Common Stock           so purchased (the “Buy-In
Price”), at which point the           Company’s obligation to deliver such
certificate (and to issue such shares           of Common Stock) or credit such Holder’s
balance account with DTC shall           terminate, or (ii) promptly honor its obligation
to deliver to the Holder a           certificate or certificates representing such shares
of Common Stock or credit           such Holder’s balance account with DTC and pay
cash to the Holder in an           amount equal to the excess (if any) of the Buy-In
Price over the product of (A)           such number of shares of Common Stock, times (B)
the Closing Bid Price on the           date of exercise.  

		    
          
          (d)           Cashless
Exercise. Notwithstanding anything contained herein to the           contrary, if a
Registration Statement (as defined in the Registration Rights           Agreement)
covering the resale of the Warrant Shares that are the subject of the           Exercise
Notice (the “Unavailable Warrant Shares”) is not           available for
the resale of such Unavailable Warrant Shares, the Holder may, in           its sole
discretion, exercise this Warrant in whole or in part and, in lieu of           making
the cash payment otherwise contemplated to be made to the Company upon           such
exercise in payment of the Aggregate Exercise Price, elect instead to           receive
upon such exercise the “Net Number” of shares of Common Stock
          determined according to the following formula (a “Cashless
          Exercise”):  

3 

			
	Net Number =
	(A x B) - (A x C)

B 
	

        For
purposes of the foregoing formula: 

        A=
the total number of shares with respect to which this Warrant is then being exercised. 

        B= the
Closing Sale Price of the shares of Common Stock (as reported by Bloomberg) on the date
immediately preceding the date of the Exercise Notice. 

        C=
the Exercise Price then in effect for the applicable Warrant Shares at the time of such
exercise. 

    
          
          (e)        Disputes.
In the case of a dispute as to the determination of the                     Exercise
Price or the arithmetic calculation of the Warrant Shares, the Company
                    shall promptly issue to the Holder the number of Warrant Shares that
are not                     disputed and resolve such dispute in accordance with Section
12.  

    
          
          (f)        Limitations
on Exercises.  

		    (i)               Beneficial
Ownership. The Company shall not effect the exercise of this
                    Warrant, and the Holder shall not have the right to exercise this
Warrant, to                     the extent that after giving effect to such exercise,
such Person (together with                     such Person’s affiliates) would
beneficially own in excess of 4.99% (the                     “Maximum Percentage”)
of the shares of Common Stock outstanding                     immediately after giving
effect to such exercise. For purposes of the foregoing                     sentence, the
aggregate number of shares of Common Stock beneficially owned by                     such
Person and its affiliates shall include the number of shares of Common
                    Stock issuable upon exercise of this Warrant with respect to which
the                     determination of such sentence is being made, but shall exclude
shares of Common                     Stock which would be issuable upon (A) exercise of
the remaining, unexercised                     portion of this Warrant beneficially owned
by such Person and its affiliates and                     (B) exercise or conversion of
the unexercised or unconverted portion of any                     other securities of the
Company beneficially owned by such Person and its                     affiliates
(including, without limitation, any convertible notes or convertible
                    preferred stock or warrants) subject to a limitation on conversion or
exercise                     analogous to the limitation contained herein. Except as set
forth in the                     preceding sentence, for purposes of this paragraph,
beneficial ownership shall                     be calculated in accordance with Section
13(d) of the Securities Exchange Act of                     1934, as amended (the “Exchange
Act”). For purposes of this                     Warrant, in determining the
number of outstanding shares of Common Stock, the                     Holder may rely on
the number of outstanding shares of Common Stock as reflected                     in (1)
the Company’s most recent Form 10-K, Form 10-KSB, Form 10-Q, Form
                    10-QSB, Current  

4 

		Report on
Form 8-K or other public filing with the Securities and Exchange Commission, as the case
may be, (2) a more recent public announcement by the Company or (3) any other notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock
outstanding. For any reason at any time, upon the written or oral request of the Holder,
the Company shall within one (1) Business Day confirm orally and in writing to the Holder
the number of shares of Common Stock then outstanding. In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including the SPA Securities and the
SPA Warrants, by the Holder and its affiliates since the date as of which such number of
outstanding shares of Common Stock was reported. By written notice to the Company, the
Holder may from time to time increase or decrease the Maximum Percentage to any other
percentage not in excess of 9.99% specified in such notice; provided that (i) any such
increase will not be effective until the sixty-first (61st) day after such
notice is delivered to the Company, and (ii) any such increase or decrease will apply
only to the Holder and not to any other holder of SPA Warrants. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict
conformity with the terms of this Section 1(f) to correct this paragraph (or any portion
hereof) which may be defective or inconsistent with the intended beneficial ownership
limitation herein contained or to make changes or supplements necessary or desirable to
properly give effect to such limitation.  

		    (ii)        Principal
Market Regulation. The Company shall not be obligated to issue
                    any shares of Common Stock upon exercise of this Warrant or
conversion of SPA                     Securities and no Buyer shall be entitled to
receive any shares of Common Stock                     if the issuance of such shares of
Common Stock would exceed that number of                     shares of Common Stock which
the Company may issue upon exercise or conversion,                     as applicable, of
the SPA Warrants and SPA Securities or otherwise without                     breaching
the Company’s obligations under the rules or regulations of any
                    applicable Eligible Market (the “Exchange Cap”),
except that                     such limitation shall not apply in the event that the
Company (A) obtains the                     approval of its shareholders as required by
the applicable rules of the Eligible                     Market for issuances of shares
of Common Stock in excess of such amount or (B)                     obtains a written
opinion from outside counsel to the Company that such approval                     is not
required, which opinion shall be reasonably satisfactory to the Required
                    Holders. Until such approval or written opinion is obtained, no Buyer
shall be                     issued in the aggregate, upon exercise or conversion, as
applicable, of any SPA                     Warrants or SPA Securities, shares of Common
Stock in an amount greater than the                     product of the Exchange Cap
multiplied by a fraction, the numerator of which is                     the total number
of shares of Common Stock underlying the SPA Warrants issued to                     such
Buyer pursuant to the Securities Purchase Agreement on the Issuance Date
                    and the denominator of which is the aggregate number of shares of
Common Stock                     underlying the SPA Warrants issued to the Buyers
pursuant to the Securities                     Purchase Agreement on the Issuance Date
(with respect to each Buyer, the                     “Exchange Cap Allocation”).
In the event that any Buyer shall                     sell or otherwise transfer any of
such Buyer’s SPA Warrants, the transferee                     shall be allocated a
pro rata portion of such Buyer’s Exchange Cap                     Allocation, and
the restrictions of the prior sentence shall apply to such                     transferee
with respect to the portion of the Exchange Cap Allocation allocated
                    to such transferee. In the event that any holder of SPA Warrants
shall exercise                     all of such holder’s SPA Warrants into a number
of shares of Common Stock                     which, in the aggregate, is less than such
holder’s Exchange Cap                     Allocation, then the difference between
such holder’s Exchange Cap                     Allocation and the number of shares
of Common Stock actually issued to such                     holder shall be allocated to
the respective Exchange Cap Allocations of the                     remaining holders of
SPA Warrants on a pro rata basis in proportion to the                     shares of
Common Stock underlying the SPA Warrants then held by each such
                    holder. In the event that the Company is prohibited from issuing any
Warrant                     Shares for which an Exercise Notice has been received as a
result of the                     operation of this Section 1(f)(ii), the Company shall
pay cash in exchange for                     cancellation of such Warrant Shares, at a
price per Warrant Share equal to the                     difference between the Closing
Sale Price and the Exercise Price as of the date                     of the attempted
exercise.  

5 

    
          
          (g)           Insufficient
Authorized Shares. If at any time while this Warrant remain           outstanding the
Company does not have a sufficient number of authorized and           unreserved shares
of Common Stock to satisfy its obligation to reserve for           issuance upon exercise
of this Warrant at least a number of shares of Common           Stock equal to 130% (the
“Required Reserve Amount”) of the           number of shares of Common
Stock as shall from time to time be necessary to           effect the exercise of all of
this Warrant then outstanding (an           “Authorized Share Failure”),
then the Company shall immediately           take all action necessary to increase the
Company’s authorized shares of           Common Stock to an amount sufficient to
allow the Company to reserve the           Required Reserve Amount for this Warrant then
outstanding. Without limiting the           generality of the foregoing sentence, as soon
as practicable after the date of           the occurrence of an Authorized Share Failure,
but in no event later than ninety           (90) days after the occurrence of such
Authorized Share Failure, the Company           shall hold a meeting of its stockholders
for the approval of an increase in the           number of authorized shares of Common
Stock. In connection with such meeting,           the Company shall provide each
stockholder with a proxy statement and shall use           its best efforts to solicit
its stockholders’ approval of such increase in           authorized shares of Common
Stock and to cause its board of directors to           recommend to the stockholders that
they approve such proposal.  

6 

	 	2.  	ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise
                    Price and the number of Warrant Shares shall be adjusted from time to
time as                     follows:  

    
          
          (a)        Adjustment
upon Issuance of shares of Common Stock. If and whenever on or
                    after the Subscription Date the Company issues or sells, or in
accordance with                     this Section 2 is deemed to have issued or sold, any
shares of Common Stock                     (including the issuance or sale of shares of
Common Stock owned or held by or                     for the account of the Company, but
excluding shares of Common Stock deemed to                     have been issued by the
Company in connection with any Excluded Securities) for                     a
consideration per share (the “New Issuance Price”) less than
                    the Exercise Price (the “Applicable Price”) in
effect                     immediately prior to such issue or sale or deemed issuance or
sale (the                     foregoing a “Dilutive Issuance”), then
immediately after such                     Dilutive Issuance, the Exercise Price then in
effect shall be reduced to an                     amount equal to the New Issuance Price.
Upon each such adjustment of the                     Exercise Price hereunder, the number
of Warrant Shares shall be adjusted to the                     number of shares of Common
Stock determined by multiplying the Exercise Price in                     effect
immediately prior to such adjustment by the number of Warrant Shares
                    acquirable upon exercise of this Warrant immediately prior to such
adjustment                     and dividing the product thereof by the Exercise Price
resulting from such                     adjustment. For purposes of determining the
adjusted Exercise Price under this                     Section 2(a), the following shall
be applicable:  

		    (i)        Issuance
of Options. If the Company in any manner grants any Options and
                    the lowest price per share for which one share of Common Stock is
issuable upon                     the exercise of any such Option or upon conversion,
exercise or exchange of any                     Convertible Securities issuable upon
exercise of any such Option is less than                     the Applicable Price, then
such share of Common Stock shall be deemed to be                     outstanding and to
have been issued and sold by the Company at the time of the                     granting
or sale of such Option for such price per share. For purposes of this
                    Section 2(a)(i), the “lowest price per share for which one share
of Common                     Stock is issuable upon exercise of such Options or upon
conversion, exercise or                     exchange of such Convertible Securities
issuable upon exercise of any such                     Option” shall be equal to the
sum of the lowest amounts of consideration                     (if any) received or
receivable by the Company with respect to any one share of                     Common
Stock upon the granting or sale of the Option, upon exercise of the
                    Option and upon conversion, exercise or exchange of any Convertible
Security                     issuable upon exercise of such Option. No further adjustment
of the Exercise                     Price or number of Warrant Shares shall be made upon
the actual issuance of such                     shares of Common Stock or of such
Convertible Securities upon the exercise of                     such Options or upon the
actual issuance of such shares of Common Stock upon                     conversion,
exercise or exchange of such Convertible Securities.  

7 

		    (ii)        Issuance
of Convertible Securities. If the Company in any manner issues                     or
sells any Convertible Securities and the lowest price per share for which one
                    share of Common Stock is issuable upon the conversion, exercise or
exchange                     thereof is less than the Applicable Price, then such share
of Common Stock shall                     be deemed to be outstanding and to have been
issued and sold by the Company at                     the time of the issuance or sale of
such Convertible Securities for such price                     per share. For the
purposes of this Section 2(a)(ii), the “lowest price per                     share
for which one share of Common Stock is issuable upon the conversion,
                    exercise or exchange thereof” shall be equal to the sum of the
lowest                     amounts of consideration (if any) received or receivable by
the Company with                     respect to one share of Common Stock upon the
issuance or sale of the                     Convertible Security and upon conversion,
exercise or exchange of such                     Convertible Security. No further
adjustment of the Exercise Price or number of                     Warrant Shares shall be
made upon the actual issuance of such shares of Common                     Stock upon
conversion, exercise or exchange of such Convertible Securities, and
                    if any such issue or sale of such Convertible Securities is made upon
exercise                     of any Options for which adjustment of this Warrant has been
or is to be made                     pursuant to other provisions of this Section 2(a),
no further adjustment of the                     Exercise Price or number of Warrant
Shares shall be made by reason of such issue                     or sale.  

		    (iii)        Change
in Option Price or Rate of Conversion. If the purchase price
                    provided for in any Options, the additional consideration, if any,
payable upon                     the issue, conversion, exercise or exchange of any
Convertible Securities, or                     the rate at which any Convertible
Securities are convertible into or exercisable                     or exchangeable for
shares of Common Stock increases or decreases at any time,                     the
Exercise Price and the number of Warrant Shares in effect at the time of
                    such increase or decrease shall be adjusted to the Exercise Price and
the number                     of Warrant Shares which would have been in effect at such
time had such Options                     or Convertible Securities provided for such
increased or decreased purchase                     price, additional consideration or
increased or decreased conversion rate, as                     the case may be, at the
time initially granted, issued or sold. For purposes of                     this Section
2(a)(iii), if the terms of any Option or Convertible Security that
                    was outstanding as of the date of issuance of this Warrant are
increased or                     decreased in the manner described in the immediately
preceding sentence, then                     such Option or Convertible Security and the
shares of Common Stock deemed                     issuable upon exercise, conversion or
exchange thereof shall be deemed to have                     been issued as of the date
of such increase or decrease. No adjustment pursuant                     to this Section
2(a)(iii) shall be made if such adjustment would result in an
                    increase of the Exercise Price then in effect or a decrease in the
number of                     Warrant Shares.  

8 

		    (iv)        Calculation
of Consideration Received. In case any Option is issued in
                    connection with the issue or sale of other securities of the Company,
together                     comprising one integrated transaction in which no specific
consideration is                     allocated to such Options by the parties thereto,
the Options will be deemed to                     have been issued for a consideration of
$0.01. If any shares of Common Stock,                     Options or Convertible
Securities are issued or sold or deemed to have been                     issued or sold
for cash, the consideration received therefor will be deemed to                     be
the net amount received by the Company therefor. If any shares of Common
                    Stock, Options or Convertible Securities are issued or sold for a
consideration                     other than cash, the amount of such consideration
received by the Company will                     be the fair value of such consideration,
except where such consideration                     consists of publicly traded
securities, in which case the amount of                     consideration received by the
Company will be the Closing Sale Price of such                     security on the date
of receipt. If any shares of Common Stock, Options or                     Convertible
Securities are issued to the owners of the non-surviving entity in
                    connection with any merger in which the Company is the surviving
entity, the                     amount of consideration therefor will be deemed to be the
fair value of such                     portion of the net assets and business of the
non-surviving entity as is                     attributable to such shares of Common
Stock, Options or Convertible Securities,                     as the case may be. The
fair value of any consideration other than cash or                     publicly traded
securities will be determined jointly by the Company and the                     Required
Holders. If such parties are unable to reach agreement within ten (10)
                    days after the occurrence of an event requiring valuation (the
                    “Valuation Event”), the fair value of such
consideration will                     be determined within five (5) Business Days after
the tenth day following the                     Valuation Event by an independent,
reputable appraiser jointly selected by the                     Company and the Required
Holders. The determination of such appraiser shall be                     final and
binding upon all parties absent manifest error and the fees and
                    expenses of such appraiser shall be borne by the Company.  

		    (v)        Record
Date. If the Company takes a record of the holders of shares of
                    Common Stock for the purpose of entitling them (A) to receive a
dividend or                     other distribution payable in shares of Common Stock,
Options or in Convertible                     Securities or (B) to subscribe for or
purchase shares of Common Stock,                     Options or Convertible Securities,
then such record date will be deemed to be                     the date of the issue or
sale of the shares of Common Stock deemed to have been                     issued or sold
upon the declaration of such dividend or the making of such other
                    distribution or the date of the granting of such right of
subscription or                     purchase, as the case may be.  

		    (vi)        Voluntary
Adjustment By Company. The Company may at any time during the
                    term of this Warrant reduce the then current  Exercise
                    Price to any amount and for any period of time deemed
appropriate by the                     Board of Directors of the Company.  

9 

		    (vii)        Automatic
Adjustment. On each of November [__], 2008 and August [__],                     2009
(each, an “Adjustment  Date”), if 75% of the Average
                    Market Price (as defined in the SPA Securities) is less than the then
existing                     Exercise Price, the then current Exercise Price hereunder
shall be reset to 75%                     of the Average Market Price (as defined in the
SPA Securities) as of the                     applicable Adjustment Date; provided, in no
event shall such reset result in an                     increase in the then existing
Exercise Price.  

		    (viii)        Milestone
Adjustment. If the Company fails any Financial Milestone (as
                    defined in the SPA Securities) (each a “Milestone Failure”)
the                     then current Exercise Price hereunder shall be reset on the tenth
(10th) Trading                     Date after the earlier to occur of the applicable
Announcement Date (as defined                     in the SPA Securities) or Announcement
Date Deadline (as defined in the SPA                     Securities) to 75% of the
Average Market Price as of the date that is ten (10)                     Trading Days
after such Announcement Date or Announcement Date Deadline, as
                    applicable; provided, in no event shall such reset result in an
increase in the                     then existing Exercise Price.  

    
          
          (b)        Adjustment
upon Subdivision or Combination of shares of Common Stock. If                     the
Company at any time on or after the Subscription Date subdivides (by any
                    stock split, stock dividend, recapitalization or otherwise) one or
more classes                     of its outstanding shares of Common Stock into a greater
number of shares, the                     Exercise Price in effect immediately prior to
such subdivision will be                     proportionately reduced and the number of
Warrant Shares will be proportionately                     increased. If the Company at
any time on or after the Subscription Date combines                     (by combination,
reverse stock split or otherwise) one or more classes of its
                    outstanding shares of Common Stock into a smaller number of shares,
the Exercise                     Price in effect immediately prior to such combination
will be proportionately                     increased and the number of Warrant Shares
will be proportionately decreased.                     Any adjustment under this Section
2(b) shall become effective at the close of                     business on the date the
subdivision or combination becomes effective.  

    
          
          (c)        Other
Events. If any event occurs of the type contemplated by the
                    provisions of this Section 2 but not expressly provided for by such
provisions                     (including, without limitation, the granting of stock
appreciation rights,                     phantom stock rights or other rights with equity
features), then the                     Company’s Board of Directors will make an
appropriate adjustment in the                     Exercise Price and the number of
Warrant Shares so as to protect the rights of                     the Holder; provided
that no such adjustment pursuant to this Section 2(c) will                     increase
the Exercise Price or decrease the number of Warrant Shares as
                    otherwise determined pursuant to this Section 2.  

10 

    3.           RIGHTS
UPON DISTRIBUTION OF ASSETS. If the Company shall declare or make           any
dividend or other distribution of its assets (or rights to acquire its           assets)
to holders of shares of Common Stock, by way of return of capital or           otherwise
(including, without limitation, any distribution of cash, stock or           other
securities, property or options by way of a dividend, spin off,
          reclassification, corporate rearrangement, scheme of arrangement or other
          similar transaction) (a “Distribution”), at any time after the
          issuance of this Warrant, then, in each such case:  

    
          
          (a)                     any
Exercise Price in effect immediately prior to the close of business on the
          record date fixed for the determination of holders of shares of Common Stock
          entitled to receive the Distribution shall be reduced, effective as of the
close           of business on such record date, to a price determined by multiplying
such           Exercise Price by a fraction of which (i) the numerator shall be the
Closing Bid           Price of the shares of Common Stock on the Trading Day immediately
preceding           such record date minus the value of the Distribution (as determined
in good           faith by the Company’s Board of Directors) applicable to one share
of           Common Stock, and (ii) the denominator shall be the Closing Bid Price of the
          shares of Common Stock on the Trading Day immediately preceding such record
          date; and  

    
          
          (b)                     the
number of Warrant Shares shall be increased to a number of shares equal to           the
number of shares of Common Stock obtainable immediately prior to the close           of
business on the record date fixed for the determination of holders of shares           of
Common Stock entitled to receive the Distribution multiplied by the           reciprocal
of the fraction set forth in the immediately preceding paragraph (a);           provided
that in the event that the Distribution is of shares of common stock           (“Other
Shares of Common Stock”) of a company whose common           shares are traded
on a national securities exchange or a national automated           quotation system,
then the Holder may elect to receive a warrant to purchase           Other Shares of
Common Stock in lieu of an increase in the number of Warrant           Shares, the terms
of which shall be identical to those of this Warrant, except           that such warrant
shall be exercisable into the number of shares of Other Shares           of Common Stock
that would have been payable to the Holder pursuant to the           Distribution had the
Holder exercised this Warrant immediately prior to such           record date and with an
aggregate exercise price equal to the product of the           amount by which the
exercise price of this Warrant was decreased with respect to           the Distribution
pursuant to the terms of the immediately preceding paragraph           (a) and the number
of Warrant Shares calculated in accordance with the first           part of this
paragraph (b).  

    4.           PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS.  

    
          
          (a)           Purchase
Rights. In addition to any adjustments pursuant to Section 2           above, if at
any time the Company grants, issues or sells any Options,           Convertible
Securities or rights to purchase stock, warrants, securities or           other property
pro rata to the record holders of any class of shares of Common           Stock (the
“Purchase Rights”), then the Holder will be entitled           to
acquire, upon the terms applicable to such Purchase Rights, the aggregate
          Purchase Rights which the Holder could have acquired if the Holder had held the
          number of shares of Common Stock acquirable upon complete exercise of this
          Warrant (without regard to any limitations on the exercise of this Warrant)
          immediately before the date on which a record is taken for the grant, issuance
          or sale of such Purchase Rights, or, if no such record is taken, the date as of
          which the record holders of shares of Common Stock are to be determined for the
          grant, issue or sale of such Purchase Rights.  

11 

    
          
          (b)           Fundamental
Transactions. The Company shall not enter into or be party to           a Fundamental
Transaction unless (i)  the Successor Entity assumes in           writing all of the
obligations of the Company under this Warrant and the other           Transaction
Documents in accordance with the provisions of this Section (4)(b)           pursuant to
written agreements in form and substance satisfactory to the           Required Holders
and approved by the Required Holders prior to such Fundamental           Transaction,
including agreements to deliver to each holder of Warrants in           exchange for such
Warrants a security of the Successor Entity evidenced by a           written instrument
substantially similar in form and substance to this Warrant,           including, without
limitation, an adjusted exercise price equal to the value for           the shares of
Common Stock reflected by the terms of such Fundamental           Transaction, and
exercisable for a corresponding number of shares of capital           stock equivalent to
the shares of Common Stock acquirable and receivable upon           exercise of this
Warrant (without regard to any limitations on the exercise of           this Warrant)
prior to such Fundamental Transaction, and satisfactory to the           Required Holders
and (ii) the Successor Entity (including its Parent           Entity) is a publicly
traded corporation whose common stock is quoted on or           listed for trading on an
Eligible Market. Upon the occurrence of any Fundamental           Transaction, the
Successor Entity shall succeed to, and be substituted for (so           that from and
after the date of such Fundamental Transaction, the provisions of           this Warrant
referring to the “Company” shall refer instead to the           Successor
Entity), and may exercise every right and power of the Company and           shall assume
all of the obligations of the Company under this Warrant with the           same effect
as if such Successor Entity had been named as the Company herein.           Upon
consummation of the Fundamental Transaction, the Successor Entity shall           deliver
to the Holder confirmation that there shall be issued upon exercise of           this
Warrant at any time after the consummation of the Fundamental Transaction,           in
lieu of the shares of the Common Stock (or other securities, cash, assets or
          other property) purchasable upon the exercise of the Warrant prior to such
          Fundamental Transaction, such shares of the publicly traded Common Stock (or
its           equivalent) of the Successor Entity (including its Parent Entity) which the
          Holder would have been entitled to receive upon the happening of such
          Fundamental Transaction had this Warrant been converted immediately prior to
          such Fundamental Transaction, as adjusted in accordance with the provisions of
          this Warrant. In addition to and not in substitution for any other rights
          hereunder, prior to the consummation of any Fundamental Transaction pursuant to
          which holders of shares of Common Stock are entitled to receive securities or
          other assets with respect to or in exchange for shares of Common Stock (a
          “Corporate Event”), the Company shall make appropriate
          provision to insure that the Holder will thereafter have the right to receive
          upon an exercise of this Warrant at any time after the consummation of the
          Fundamental Transaction but prior to the Expiration Date, in lieu of the shares
          of the Common Stock (or other securities, cash, assets or other property)
          purchasable upon the exercise of the Warrant prior to such Fundamental
          Transaction, such shares of stock, securities, cash, assets or any other
          property whatsoever (including warrants or other purchase or subscription
          rights) which the Holder would have been entitled to receive upon the happening
          of such Fundamental Transaction had the Warrant been exercised immediately
prior           to such Fundamental Transaction. Provision made pursuant to the preceding
          sentence shall be in a form and substance reasonably satisfactory to the
          Required Holders. The provisions of this Section shall apply similarly and
          equally to successive Fundamental Transactions and Corporate Events and shall
be           applied without regard to any limitations on the exercise of this Warrant.  

12 

    
          
          (c)                     Notwithstanding
the foregoing and the provisions of Section 4(b) above, in the           event of a
Fundamental Transaction, at the request of the Holder delivered           before the
ninetieth (90th) day after the consummation of such Fundamental           Transaction,
the Company (or the Successor Entity) shall purchase this Warrant           from the
Holder by paying to the Holder, within five (5) Business Days of such           request
(or, if later, on the effective date of the Fundamental Transaction,           cash in an
amount equal to the Black-Scholes Value of the remaining unexercised           portion of
this Warrant on the date of such Fundamental Transaction.  

13 

    5.           WARRANT
HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically           provided
herein, the Holder, solely in such Person’s capacity as a holder           of this
Warrant, shall not be entitled to vote or receive dividends or be deemed           the
holder of share capital of the Company for any purpose, nor shall anything
          contained in this Warrant be construed to confer upon the Holder, solely in
such           Person’s capacity as the Holder of this Warrant, any of the rights of
a           shareholder of the Company or any right to vote, give or withhold consent to
any           corporate action (whether any reorganization, issue of stock,
reclassification           of stock, consolidation, merger, conveyance or otherwise),
receive notice of           meetings, receive dividends or subscription rights, or
otherwise, prior to the           issuance to the Holder of the Warrant Shares which such
Person is then entitled           to receive upon the due exercise of this Warrant. In
addition, nothing contained           in this Warrant shall be construed as imposing any
liabilities on the Holder to           purchase any securities (upon exercise of this
Warrant or otherwise) or as a           shareholder of the Company, whether such
liabilities are asserted by the Company           or by creditors of the Company.
Notwithstanding this Section 5, the Company           shall provide the Holder with
copies of the same notices and other information           given to the shareholders of
the Company generally, contemporaneously with the           giving thereof to the
shareholders.  

    6.           NONCIRCUMVENTION.
The Company hereby covenants and agrees that the           Company will not, by amendment
of its Articles of Incorporation, Bylaws or           through any reorganization,
transfer of assets, consolidation, merger, scheme of           arrangement, dissolution,
issue or sale of securities, or any other voluntary           action, avoid or seek to
avoid the observance or performance of any of the terms           of this Warrant, and
will at all times in good faith carry out all the           provisions of this Warrant
and take all action as may be required to protect the           rights of the Holder.
Without limiting the generality of the foregoing, the           Company (i) shall
not increase the par value of any shares of Common Stock           receivable upon the
exercise of this Warrant above the Exercise Price then in           effect, (ii) shall
take all such actions as may be necessary or appropriate           in order that the
Company may validly and legally issue fully paid and           nonassessable shares of
Common Stock upon the exercise of this Warrant, and           (iii) shall, so long as any
of the SPA Warrants are outstanding, take all action           necessary to reserve and
keep available out of its authorized and unissued           shares of Common Stock,
solely for the purpose of effecting the exercise of the           SPA Warrants, 130% of
the number of shares of Common Stock as shall from time to           time be necessary to
effect the exercise of the SPA Warrants then outstanding           (without regard to any
limitations on exercise).  

    7.           REISSUANCE
OF WARRANTS.  

    
          
          (a)           Transfer
of Warrant. If this Warrant is to be transferred, the Holder           shall
surrender this Warrant to the Company, whereupon the Company will           forthwith
issue and deliver upon the order of the Holder a new Warrant (in           accordance
with Section 7(d)), registered as the Holder may request,           representing the
right to purchase the number of Warrant Shares being           transferred by the Holder
and, if less than the total number of Warrant Shares           then underlying this
Warrant is being transferred, a new Warrant (in accordance           with Section 7(d))
to the Holder representing the right to purchase the number           of Warrant Shares
not being transferred.  

14 

    
          
          (b)           Lost,
Stolen or Mutilated Warrant. Upon receipt by the Company of           evidence
reasonably satisfactory to the Company of the loss, theft, destruction           or
mutilation of this Warrant, and, in the case of loss, theft or destruction,           of
any indemnification undertaking by the Holder to the Company in customary           form
and, in the case of mutilation, upon surrender and cancellation of this
          Warrant, the Company shall execute and deliver to the Holder a new Warrant (in
          accordance with Section 7(d)) representing the right to purchase the Warrant
          Shares then underlying this Warrant.  

    
          
          (c)           Exchangeable
for Multiple Warrants. This Warrant is exchangeable, upon           the surrender
hereof by the Holder at the principal office of the Company, for a           new Warrant
or Warrants (in accordance with Section 7(d)) representing in the           aggregate the
right to purchase the number of Warrant Shares then underlying           this Warrant,
and each such new Warrant will represent the right to purchase           such portion of
such Warrant Shares as is designated by the Holder at the time           of such
surrender; provided, however, that no Warrants for fractional shares of           Common
Stock shall be given.  

    
          
          (d)           Issuance
of New Warrants. Whenever the Company is required to issue a new           Warrant
pursuant to the terms of this Warrant, such new Warrant (i) shall be of           like
tenor with this Warrant, (ii) shall represent, as indicated on the face of           such
new Warrant, the right to purchase the Warrant Shares then underlying this
          Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a)
          or Section 7(c), the Warrant Shares designated by the Holder which, when added
          to the number of shares of Common Stock underlying the other new Warrants
issued           in connection with such issuance, does not exceed the number of Warrant
Shares           then underlying this Warrant), (iii) shall have an issuance date, as
indicated           on the face of such new Warrant which is the same as the Issuance
Date, and (iv)           shall have the same rights and conditions as this Warrant.  

    8.           NOTICES.
Whenever notice is required to be given under this Warrant,           unless otherwise
provided herein, such notice shall be given in accordance with           Section 9(f) of
the Securities Purchase Agreement. The Company shall provide the           Holder with
prompt written notice of all actions taken pursuant to this Warrant,           including
in reasonable detail a description of such action and the reason           therefore.
Without limiting the generality of the foregoing, the Company will           give written
notice to the Holder (i) immediately upon any adjustment of the           Exercise Price,
setting forth in reasonable detail, and certifying, the           calculation of such
adjustment and (ii) at least fifteen days prior to the date           on which the
Company closes its books or takes a record (A) with respect to any           dividend or
distribution upon the shares of Common Stock, (B) with respect to           any grants,
issuances or sales of any Options, Convertible Securities or rights           to purchase
stock, warrants, securities or other property to holders of shares           of Common
Stock or (C) for determining rights to vote with respect to any           Fundamental
Transaction, dissolution or liquidation, provided in each case that           such
information shall be made known to the public prior to or in conjunction           with
such notice being provided to the Holder.  

    9.           AMENDMENT
AND WAIVER. Except as otherwise provided herein, the provisions           of this
Warrant may be amended and the Company may take any action herein           prohibited,
or omit to perform any act herein required to be performed by it,           only if the
Company has obtained the written consent of the Required Holders;           provided that
no such action may increase the exercise price of any SPA Warrant           or decrease
the number of shares or class of stock obtainable upon exercise of           any SPA
Warrant without the written consent of the Holder. No such amendment           shall be
effective to the extent that it applies to less than all of the holders           of the
SPA Warrants then outstanding.  

15 

    10.           GOVERNING
LAW. This Warrant shall be governed by and construed and           enforced in
accordance with, and all questions concerning the construction,           validity,
interpretation and performance of this Warrant shall be governed by,           the
internal laws of the State of New York, without giving effect to any choice           of
law or conflict of law provision or rule (whether of the State of New York or
          any other jurisdictions) that would cause the application of the laws of any
          jurisdictions other than the State of New York.  

    11.           CONSTRUCTION;
HEADINGS. This Warrant shall be deemed to be jointly           drafted by the Company
and all the Buyers and shall not be construed against any           person as the drafter
hereof. The headings of this Warrant are for convenience           of reference and shall
not form part of, or affect the interpretation of, this           Warrant.  

    12.           DISPUTE
RESOLUTION. In the case of a dispute as to the determination of           the
Exercise Price or the arithmetic calculation of the Warrant Shares, the           Company
shall submit the disputed determinations or arithmetic calculations via
          facsimile within two Business Days of receipt of the Exercise Notice giving
rise           to such dispute, as the case may be, to the Holder. If the Holder and the
          Company are unable to agree upon such determination or calculation of the
          Exercise Price or the Warrant Shares within three Business Days of such
disputed           determination or arithmetic calculation being submitted to the Holder,
then the           Company shall, within two Business Days submit via facsimile (a) the
disputed           determination of the Exercise Price to an independent, reputable
investment bank           selected by the Company and approved by the Holder or (b) the
disputed           arithmetic calculation of the Warrant Shares to the Company’s
independent,           outside accountant. The Company shall cause at its expense the
investment bank           or the accountant, as the case may be, to perform the
determinations or           calculations and notify the Company and the Holder of the
results no later than           ten Business Days from the time it receives the disputed
determinations or           calculations. Such investment bank’s or accountant’s
determination or           calculation, as the case may be, shall be binding upon all
parties absent           demonstrable error.  

    13.           REMEDIES,
OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies           provided in
this Warrant shall be cumulative and in addition to all other           remedies
available under this Warrant and the other Transaction Documents, at           law or in
equity (including a decree of specific performance and/or other           injunctive
relief), and nothing herein shall limit the right of the Holder right           to pursue
actual damages for any failure by the Company to comply with the terms           of this
Warrant. The Company acknowledges that a breach by it of its obligations
          hereunder will cause irreparable harm to the Holder and that the remedy at law
          for any such breach may be inadequate. The Company therefore agrees that, in
the           event of any such breach or threatened breach, the holder of this Warrant
shall           be entitled, in addition to all other available remedies, to an
injunction           restraining any breach, without the necessity of showing economic
loss and           without any bond or other security being required.  

16 

    14.           TRANSFER.
This Warrant may be offered for sale, sold, transferred or           assigned without the
consent of the Company, except as may otherwise be required           by Section 2(g) of
the Securities Purchase Agreement.  

    15.           SEVERABILITY.
If any provision of this Agreement is prohibited by law or           otherwise determined
to be invalid or unenforceable by a court of competent           jurisdiction, the
provision that would otherwise be prohibited, invalid or           unenforceable shall be
deemed amended to apply to the broadest extent that it           would be valid and
enforceable, and the invalidity or unenforceability of such           provision shall not
affect the validity of the remaining provisions of this           Agreement so long as
this Agreement as so modified continues to express, without           material change,
the original intentions of the parties as to the subject matter           hereof and the
prohibited nature, invalidity or unenforceability of the           provision(s) in
question does not substantially impair the respective           expectations or
reciprocal obligations of the parties or the practical           realization of the
benefits that would otherwise be conferred upon the parties.           The parties will
endeavor in good faith negotiations to replace the prohibited,           invalid or
unenforceable provision(s) with a valid provision(s), the effect of           which comes
as close as possible to that of the prohibited, invalid or           unenforceable
provision(s).  

    16.           CERTAIN
DEFINITIONS. For purposes of this Warrant, the following terms           shall have
the following meanings:  

    
          
          (a)           Approved
Stock Plan” means any employee benefit plan which has been           approved by
the Board of Directors of the Company, pursuant to which the           Company’s
securities may be issued to any employee, consultant, officer or           director for
services provided to the Company.  

    
          
          (b)                     “Black
Scholes Value” means the value of this Warrant based on           the Black and
Scholes Option Pricing Model obtained from the “OV”          function on
Bloomberg determined as of the day of closing of the applicable           Fundamental
Transaction for pricing purposes and reflecting (i) a risk-free           interest rate
corresponding to the U.S. Treasury rate for a period equal to the           remaining
term of this Warrant as of such date of request, (ii) an expected           volatility
equal to the greater of 100% and the 100 day volatility obtained from           the HVT
function on Bloomberg as of the day immediately following the public
          announcement of the applicable Fundamental Transaction and (iii) the underlying
          price per share used in such calculation shall be the sum of the price per
share           being offered in cash, if any, plus the value of any non cash
consideration, if           any, being offered in the Fundamental Transaction.  

    
          
          (c)                     “Bloomberg” means
Bloomberg Financial Markets.  

    
          
          (d)                     “Business
Day” means any day other than Saturday, Sunday or           other day on which
commercial banks in The City of New York are authorized or           required by law to
remain closed.  

17 

    
          
          (e)                     “Closing
Bid Price” and “Closing Sale Price”          means, for any
security as of any date, the last closing bid price and last           closing trade
price, respectively, for such security on the Principal Market, as           reported by
Bloomberg, or, if the Principal Market begins to operate on an           extended hours
basis and does not designate the closing bid price or the closing           trade price,
as the case may be, then the last bid price or last trade price,           respectively,
of such security prior to 4:00:00 p.m., New York Time, as reported           by
Bloomberg, or, if the Principal Market is not the principal securities           exchange
or trading market for such security, the last closing bid price or last           trade
price, respectively, of such security on the principal securities exchange           or
trading market where such security is listed or traded as reported by
          Bloomberg, or if the foregoing do not apply, the last closing bid price or last
          trade price, respectively, of such security in the over-the-counter market on
          the electronic bulletin board for such security as reported by Bloomberg, or,
if           no closing bid price or last trade price, respectively, is reported for such
          security by Bloomberg, the average of the bid prices, or the ask prices,
          respectively, of any market makers for such security as reported in the
          “pink sheets” by Pink Sheets LLC (formerly the National Quotation
          Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price cannot be
          calculated for a security on a particular date on any of the foregoing bases,
          the Closing Bid Price or the Closing Sale Price, as the case may be, of such
          security on such date shall be the fair market value as mutually determined by
          the Company and the Holder. If the Company and the Holder are unable to agree
          upon the fair market value of such security, then such dispute shall be
resolved           pursuant to Section 12. All such determinations to be appropriately
adjusted for           any stock dividend, stock split, stock combination or other
similar transaction           during the applicable calculation period.  

    
          
          (f)                     “Common
Stock” means (i) the Company’s shares of           Common Stock, par
value $0.001 per share, and (ii) any share capital into           which such Common
Stock shall have been changed or any share capital resulting           from a
reclassification of such Common Stock.  

    
          
          (g)                     “Convertible
Securities” means any stock or securities (other           than Options)
directly or indirectly convertible into or exercisable or           exchangeable for
shares of Common Stock.  

    
          
          (h)                     “Eligible
Market” means the Principal Market, the American           Stock Exchange, The
New York Stock Exchange, Inc., The NASDAQ Global Market, The           NASDAQ Capital
Market or The NASDAQ Global Select Market.  

    
          
          (i)                     “Excluded
Securities” means any Common Stock issued or           issuable: (i) in
connection with any Approved Stock Plan; (ii) upon conversion           of the SPA
Securities or the exercise of the SPA Warrants; (iii) in connection           with the
payment of any Interest Shares on the SPA Securities; and (iv) upon           exercise of
any Options or Convertible Securities which are outstanding on the           day
immediately preceding the Subscription Date, provided that the terms of such
          Options or Convertible Securities are not amended, modified or changed on or
          after the Subscription Date.  

    
          
          (j)
                     “Expiration
Date” means nine (9) years after the Issuance           Date, but if such date
falls on a day other than a Business Day or on which           trading does not take
place on the Principal market (a           “Holiday”), the next day that
is not a Holiday.  

18 

    
          
          (k)                     “Fundamental
Transaction” means that the Company shall directly           or indirectly, in
one or more related transactions, (i) consolidate or merge           with or into
(whether or not the Company is the surviving corporation) another           Person, or
(ii) sell, assign, transfer, convey or otherwise dispose of all or
          substantially all of the properties or assets of the Company to another Person,
          or (iii) allow another Person to make a purchase, tender or exchange offer that
          is accepted by the holders of more than the 50% of either the outstanding
shares           of Common Stock (not including any shares of Common Stock held by the
Person or           Persons making or party to, or associated or affiliated with the
Persons making           or party to, such purchase, tender or exchange offer), or (iv)
consummate a           stock purchase agreement or other business combination (including,
without           limitation, a reorganization, recapitalization, spin-off or scheme of
          arrangement) with another Person whereby such other Person acquires more than
          the 50% of the outstanding shares of Common Stock (not including any shares of
          Common Stock held by the other Person or other Persons making or party to, or
          associated or affiliated with the other Persons making or party to, such stock
          purchase agreement or other business combination), or (v) reorganize,
          recapitalize or reclassify its Common Stock, or (vi) any “person” or
          “group” (as these terms are used for purposes of Sections 13(d) and
          14(d) of the Exchange Act), become the “beneficial owner” (as defined
          in Rule 13d-3 under the Exchange Act), directly or indirectly, of 50% of the
          aggregate ordinary voting power represented by issued and outstanding Common
          Stock.  

    
          
          (l)                     “Options” means
any rights, warrants or options to subscribe           for or purchase shares of Common
Stock or Convertible Securities.  

    
          
          (m)                     “Parent
Entity” of a Person means an entity that, directly or           indirectly,
controls the applicable Person and whose common stock or equivalent           equity
security is quoted or listed on an Eligible Market, or, if there is more           than
one such Person or Parent Entity, the Person or Parent Entity with the           largest
public market capitalization as of the date of consummation of the           Fundamental
Transaction.  

    
          
          (n)                     “Person” means
an individual, a limited liability company, a           partnership, a joint venture, a
corporation, a trust, an unincorporated           organization, any other entity and a
government or any department or agency           thereof.  

    
          
          (o)                     “Principal
Market” means the OTC Bulletin Board.  

    
          
          (p)                     “Registration
Rights Agreement” means that certain Registration           Rights Agreement
dated as of the Issuance Date by and among the Company and the           Buyers.  

    
          
          (q)                     “Required
Holders” means the holders of the SPA Warrants           representing at least a
majority of shares of Common Stock underlying the SPA           Warrants then
outstanding.  

    
          
          (r)                     “SPA
Securities” means the Notes issued pursuant to the           Securities Purchase
Agreement.  

    
          
          (s)                     “Successor
Entity” means the Person (or, if so elected by the           Required Holders,
the Parent Entity) formed by, resulting from or surviving any           Fundamental
Transaction or the Person (or, if so elected by the Required           Holders, the
Parent Entity) with which such Fundamental Transaction shall have           been entered
into.  

19 

    
          
          (t)                     “Trading
Day” means any day on which the Common Stock is traded           on the
Principal Market, or, if the Principal Market is not the principal           trading
market for the Common Stock, then on the principal securities exchange           or
securities market on which the Common Stock is then traded; provided that           “Trading
Day” shall not include any day on which the Common Stock is           scheduled to
trade on such exchange or market for less than 4.5 hours or any day           that the
Common Stock is suspended from trading during the final hour of trading           on such
exchange or market (or if such exchange or market does not designate in           advance
the closing time of trading on such exchange or market, then during the           hour
ending at 4:00:00 p.m., New York Time).  

    
          
          (u)                     “Weighted
Average Price” means, for any security as of any           date, the dollar
volume-weighted average price for such security on the           Principal Market during
the period beginning at 9:30:01 a.m., New York Time (or           such other time as the
Principal Market publicly announces is the official open           of trading), and
ending at 4:00:00 p.m., New York Time (or such other time as           the Principal
Market publicly announces is the official close of trading) as           reported by
Bloomberg through its “Volume at Price” functions, or, if           the
foregoing does not apply, the dollar volume-weighted average price of such
          security in the over-the-counter market on the electronic bulletin board for
          such security during the period beginning at 9:30:01 a.m., New York Time (or
          such other time as such market publicly announces is the official open of
          trading), and ending at 4:00:00 p.m., New York Time (or such other time as such
          market publicly announces is the official close of trading) as reported by
          Bloomberg, or, if no dollar volume-weighted average price is reported for such
          security by Bloomberg for such hours, the average of the highest closing bid
          price and the lowest closing ask price of any of the market makers for such
          security as reported in the “pink sheets” by Pink Sheets LLC
(formerly           the National Quotation Bureau, Inc.). If the Weighted Average Price
cannot be           calculated for a security on a particular date on any of the
foregoing bases,           the Weighted Average Price of such security on such date shall
be the fair           market value as mutually determined by the Company and the Holder.
If the           Company and the Holder are unable to agree upon the fair market value of
such           security, then such dispute shall be resolved pursuant to Section 12. All
such           determinations are to be appropriately adjusted for any stock dividend,
stock           split, stock combination or other similar transaction during the
applicable           calculation period.  

[Signature Page
Follows] 

20 

        IN
WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to be
duly executed as of the Issuance Date set out above. 

		
		AMISH NATURALS, INC.

By:                 

Name:

Title:

21 

EXHIBIT A 

EXERCISE NOTICE 

TO BE EXECUTED BY THE
REGISTERED HOLDER TO EXERCISE THIS 
WARRANT TO PURCHASE
COMMON STOCK 

AMISH NATURALS, INC. 

        The
undersigned holder hereby exercises the right to purchase _________________ of the shares
of Common Stock (“Warrant Shares”) of Amish Naturals, Inc., a Nevada
corporation (the “Company”), evidenced by the attached Warrant to
Purchase Common Stock (the “Warrant”). Capitalized terms used herein and
not otherwise defined shall have the respective meanings set forth in the Warrant. 

         1.       
          Form of Exercise Price. The Holder intends that payment of the Exercise Price
          shall be made as: 

					
		____________
	
a "Cash Exercise" with respect to

Warrant Shares; and/or
	____________ 	

					
		____________
	
a "Cashless Exercise" with respect to

    Warrant Shares.

	____________ 	

         2.       
          Payment of Exercise Price. In the event that the holder has elected a Cash
          Exercise with respect to some or all of the Warrant Shares to be issued pursuant
          hereto, the holder shall pay the Aggregate Exercise Price in the sum of
          $___________________ to the Company in accordance with the terms of the Warrant. 

         3.       
          Delivery of Warrant Shares. The Company shall deliver to the holder __________
          Warrant Shares in accordance with the terms of the Warrant. 

Date: _______________ __, ______ 

___________________________
Name of Registered Holder 

By: ___________________________

                                                 
Name: ___________________________

Title:___________________________ 

ACKNOWLEDGMENT 

        The
Company hereby acknowledges this Exercise Notice and hereby directs American Stock
Transfer & Trust Company to issue the above indicated number of shares of
Common Stock in accordance with the Transfer Agent Instructions dated February [__], 2008
from the Company and acknowledged and agreed to by American Stock Transfer & Trust
Company. 

		
		AMISH NATURALS, INC.

By:__________________________ 

         Name:

         Title:Exhibit 10.16 

NEITHER THIS SECURITY NOR THE
SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS
AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE
OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES
ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES. 

COMMON STOCK PURCHASE
WARRANT 

To Purchase 156,250
Shares of Common Stock 

of 

Amish Naturals, Inc. 

        THIS
COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Wharton Capital
Partners, Ltd. (the “Holder”), is entitled, upon the terms and subject to
the limitations on exercise and the conditions hereinafter set forth, at any time on or
after February __, 2008 (the “Initial Exercise Date”), and on or prior to
the close of business on February __, 2013 (the “Termination Date”), but
not thereafter, to subscribe for and purchase from Amish Naturals, Inc., a corporation
incorporated in the State of Nevada (the “Company”), up to 156,250 shares
(the “Warrant Shares”) of Common Stock of the Company (the
“Common Stock”). The initial purchase price of one share of Common Stock
under this Warrant shall be $1.52 (the “Initial Exercise Price”),
subject to adjustment herein. The Initial Exercise Price and the number of Warrant Shares
for which the Warrant is exercisable shall be subject to adjustment as provided herein. 

        1.    Title
to Warrant. Prior to the Termination Date and subject to compliance           with
applicable laws and Section 7 of this Warrant, this Warrant and all rights
          hereunder are transferable, in whole or in part, at the office or agency of the
          Company by the Holder in person or by duly authorized attorney, upon surrender
          of this Warrant together with the Assignment Form annexed hereto properly
          endorsed. The transferee shall sign an investment letter in form and substance
          reasonably satisfactory to the Company.  

        2.    Authorization
of Shares. The Company covenants that all Warrant Shares           which may be
issued upon the exercise of the purchase rights represented by this           Warrant
will, upon exercise of the purchase rights represented by this Warrant,           be duly
authorized, validly issued, fully paid and nonassessable and free from           all
taxes, liens and charges in respect of the issue thereof (other than taxes           in
respect of any transfer occurring contemporaneously with such issue).  

1 

        3.
   Exercise of Warrant.  

    
          (a)                             Except
as provided in Section 4 of this Warrant, exercise of the purchase rights
               represented by this Warrant, in whole or in part, may be made at any time
or                times on or after the Initial Exercise Date and on or before the
Termination                Date by the surrender of this Warrant and the Notice of
Exercise Form annexed                hereto duly executed, at the office of the Company
(or such other office or                agency of the Company as it may designate by
notice in writing to the registered                Holder at the address of such Holder
appearing on the books of the Company) and                upon payment of the Exercise
Price (as defined below) for the number of Warrant                Shares with respect to
which this Warrant is then being exercised, payable by                certified or
official bank check or by wire transfer to an account designated by                the
Company.  

    
          (b)       Upon
payment of the Exercise Price pursuant to Section 3(a) of this Warrant, the
          Holder shall be entitled to receive a certificate for the number of Warrant
          Shares so purchased. Certificates for shares purchased hereunder shall be
          delivered to the Holder within five (5) Trading Days after the date on which
          this Warrant shall have been exercised as aforesaid. This Warrant shall be
          deemed to have been exercised and such certificate or certificates shall be
          deemed to have been issued, and the Holder or any other person so designated to
          be named therein shall be deemed to have become a holder of record of such
          shares for all purposes, as of the date the Warrant has been exercised, by
          payment to the Company of the Exercise Price and all taxes required to be paid
          by the Holder, if any, pursuant to Section 5 of this Warrant, prior to the
          issuance of such shares. “Trading Day” means (i) a day on
which           the Common Stock is traded on the OTC Bulletin Board, or (ii) if the
Common           Stock is not listed on the OTC Bulletin Board, a day on which the Common
Stock           is traded on any other registered national stock exchange, or (iii) if
the           Common Stock is not traded on the OTC Bulletin Board or any other
registered           national stock exchange, a day on which the Common Stock is quoted
in the           over-the-counter market as reported by the Pink Sheets LLC (or any
similar           organization or agency succeeding its functions of reporting prices);
provided,           however, that in the event that the Common Stock is not listed or
quoted as set           forth in (i), (ii) and (ii) of this Section 3(b), then Trading
Day shall mean           any day except Saturday, Sunday and any day which shall be a
legal holiday or a           day on which banking institutions in the State of New York
are authorized or           required by law or other government action to close.  

    
          (c)       If
the Company fails to deliver to the Holder a certificate or certificates
          representing the Warrant Shares pursuant to Section 3(b) of this Warrant by the
          close of business on the fifth Trading Day after the date of exercise, then the
          Holder will have the right to rescind such exercise. In addition, if the
Company           fails to deliver to the Holder a certificate or certificates
representing the           Warrant Shares pursuant to an exercise by the close of
business on the fifth           Trading Day after the date of exercise, and if after such
fifth Trading Day the           Holder is required by its broker to purchase (in an open
market transaction or           otherwise) shares of Common Stock to deliver in
satisfaction of a sale by the           Holder of the Warrant Shares which the Holder
anticipated receiving upon such           exercise (a “Buy-In”), then
the Company shall (i) pay in cash           to the Holder the amount by which (x) the
Holder’s total purchase price           (including brokerage commissions, if any)
for the shares of Common Stock so           purchased exceeds (y) the amount obtained by
multiplying (A) the number of           Warrant Shares that the Company was required to
deliver to the Holder in           connection with the exercise at issue times (B) the
price at which the sell           order giving rise to such purchase obligation was
executed, and (ii) at the           option of the Holder, either reinstate the portion of
the Warrant and equivalent           number of Warrant Shares for which such exercise was
not honored or deliver to           the Holder the number of shares of Common Stock that
would have been issued had           the Company timely complied with its exercise and
delivery obligations           hereunder. For example, if the Holder purchases Common
Stock having a total           purchase price of $11,000 to cover a Buy-In with respect
to an attempted           exercise of Warrant Shares with an aggregate sale price giving
rise to such           purchase obligation of $10,000, under clause (i) of the
immediately preceding           sentence the Company shall be required to pay the Holder
$1,000. The Holder           shall provide the Company written notice indicating the
amounts payable to the           Holder in respect of the Buy-In, together with
applicable confirmations and           other evidence reasonably requested by the
Company. Nothing herein shall limit a           Holder’s right to pursue any other
remedies available to it hereunder, at           law or in equity including, without
limitation, a decree of specific performance           and/or injunctive relief with
respect to the Company’s failure to timely           deliver certificates
representing Warrant Shares upon exercise of this Warrant           as required pursuant
to the terms hereof.  

2 

    
          (d)       If
this Warrant shall have been exercised in part, the Company shall, at the           time
of delivery of the certificate or certificates representing Warrant Shares,
          deliver to the Holder a new Warrant evidencing the rights of the Holder to
          purchase the unpurchased Warrant Shares called for by this Warrant, which new
          Warrant shall in all other respects be identical with this Warrant.  

    4.       No
Fractional Shares or Scrip. No fractional shares or scrip representing
          fractional shares shall be issued upon the exercise of this Warrant. As to any
          fraction of a share which the Holder would otherwise be entitled to purchase
          upon such exercise, the Company shall pay a cash adjustment in respect of such
          final fraction in an amount equal to such fraction multiplied by the Exercise
          Price.  

    5.       Charges,
Taxes and Expenses. Issuance of certificates for Warrant Shares           shall be
made without charge to the Holder for any issue or transfer tax or           other
incidental expense in respect of the issuance of such certificate, all of           which
taxes and expenses shall be paid by the Company, and such certificates           shall be
issued in the name of the Holder or in such name or names as may be           directed by
the Holder; provided, however, that in the event certificates for           Warrant
Shares are to be issued in a name other than the name of the Holder,           this
Warrant when surrendered for exercise shall be accompanied by the           Assignment
Form attached hereto duly executed by the Holder; and the Company may           require,
as a condition thereto, the payment of a sum sufficient to reimburse it           for any
transfer tax incidental thereto.  

    6.       Closing
of Books. The Company will not close its stockholder books or           records in
any manner which prevents the timely exercise of this Warrant,           pursuant to the
terms hereof.  

    7.       Transfer,
Division and Combination. 

    
          (a)       Subject
to compliance with any applicable securities laws and the conditions set           forth
in Section 7(e) of this Warrant, this Warrant and all rights hereunder are
          transferable, in whole or in part, upon surrender of this Warrant at the
          principal office of the Company, together with a written assignment of this
          Warrant substantially in the form attached hereto duly executed by the Holder
or           its agent or attorney and funds sufficient to pay any transfer taxes payable
          upon the making of such transfer. Upon such surrender and, if required, such
          payment, the Company shall execute and deliver a new Warrant or Warrants in the
          name of the assignee or assignees and in the denomination or denominations
          specified in such instrument of assignment, and shall issue to the assignor a
          new Warrant evidencing the portion of this Warrant not so assigned, and this
          Warrant shall promptly be cancelled. A Warrant, if properly assigned, may be
          exercised by a new holder for the purchase of Warrant Shares without having a
          new Warrant issued.  

3 

    
          (b)       This
Warrant may be divided or combined with other Warrants upon presentation           hereof
at the aforesaid office of the Company, together with a written notice
          specifying the names and denominations in which new Warrants are to be issued,
          signed by the Holder or its agent or attorney. Subject to compliance with
          Section 7(a) of this Warrant, as to any transfer which may be involved in such
          division or combination, the Company shall execute and deliver a new Warrant or
          Warrants in exchange for the Warrant or Warrants to be divided or combined in
          accordance with such notice.  

    
          (c)       The
Company shall prepare, issue and deliver at its own expense (other than
          transfer taxes) the new Warrant or Warrants under this Section 7.  

    
          (d)       The
Company agrees to maintain, at its aforesaid office, books for the           registration
and the registration of transfer of the Warrants.  

    
          (e)       If,
at the time of the surrender of this Warrant in connection with any transfer           of
this Warrant, the transfer of this Warrant shall not be registered pursuant           to
an effective registration statement under the Securities Act and under
          applicable state securities or blue sky laws, the Company may require, as a
          condition of allowing such transfer (i) that the Holder or transferee of this
          Warrant, as the case may be, furnish to the Company a written opinion of
counsel           (which opinion shall be in form, substance and scope customary for
opinions of           counsel in comparable transactions) to the effect that such
transfer may be made           without registration under the Securities Act and under
applicable state           securities or blue sky laws, (ii) that the Holder or
transferee execute and           deliver to the Company an investment letter in form and
substance acceptable to           the Company and (iii) that the transferee be an “accredited
investor”          as defined in Rule 501(a) promulgated under the Securities Act.  

    8.       No
Rights as Shareholder until Exercise. This Warrant does not entitle           the
Holder to any voting rights or other rights as a shareholder of the Company
          prior to the exercise hereof. Upon the surrender of this Warrant and the
payment           of the aggregate Exercise Price (or by means of a cashless exercise),
the           Warrant Shares so purchased shall be and be deemed to be issued to such
Holder           as the record owner of such shares as of the close of business on the
later of           the date of such surrender or payment. Notwithstanding the foregoing,
in the           event the Company grants rights to all shareholders to purchase Common
Stock,           the Holder shall have the same rights as if this Warrant had been
exercised           immediately prior to such grant.  

    9.       Loss,
Theft, Destruction or Mutilation of Warrant. The Company covenants           that
upon receipt by the Company of evidence reasonably satisfactory to it of           the
loss, theft, destruction or mutilation of this Warrant or any stock           certificate
relating to the Warrant Shares, and in case of loss, theft or           destruction, of
indemnity or security reasonably satisfactory to it (which, in           the case of the
Warrant, shall not include the posting of any bond), and upon           surrender and
cancellation of such Warrant or stock certificate, if mutilated,           the Company
will make and deliver a new Warrant or stock certificate of like           tenor and
dated as of such cancellation, in lieu of such Warrant or stock           certificate.  

4 

    10.       Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the           taking of any
action or the expiration of any right required or granted herein           shall be a
Saturday, Sunday or a legal holiday, then such action may be taken or           such
right may be exercised on the next succeeding day not a Saturday, Sunday or
          legal holiday.  

    11.       Adjustments
of Exercise Price and Number of Warrant Shares. The initial           purchase price
of one share of Common Stock under this Warrant shall be $2.47(the “Initial
Exercise Price”). The number and kind of           securities purchasable upon
the exercise of this Warrant and the Initial           Exercise Price shall be adjusted
as provided for in this Section 11 (the Initial           Exercise Price, and the Initial
Exercise Price as thereafter then adjusted,           shall be referred to herein as the
“Exercise Price”) and the           Exercise Price from time to time
shall be further adjusted as provided for in           this Section 11. Upon each such
adjustment of the kind and number of Warrant           Shares or other securities of the
Company which are purchasable hereunder, the           Holder shall thereafter be
entitled to purchase the number of Warrant Shares or           other securities resulting
from such adjustment at an Exercise Price per Warrant           Share or other security
obtained by multiplying the Exercise Price in effect           immediately prior to such
adjustment by the number of Warrant Shares purchasable           pursuant hereto
immediately prior to such adjustment and dividing by the number           of Warrant
Shares or other securities of the Company that are purchasable           pursuant hereto
immediately after such adjustment. Upon each adjustment of the           Exercise Price,
the Holder shall thereafter be entitled to receive upon exercise           of this
Warrant, at the Exercise Price resulting from such adjustment, the           number of
Warrant Shares obtained by (i) multiplying the Exercise Price effect
          immediately prior to such adjustment by the number of Warrant Shares
purchasable           hereunder immediately prior to such adjustment, and (ii) dividing
the product           thereof by the Exercise Price resulting from such adjustment. An
adjustment made           pursuant to this Section 11 shall become effective immediately
after the           effective date of such event retroactive to the record date, if any,
for such           event. This Warrant need not be changed because of any adjustment made
pursuant           to this Section 11. The Exercise Price shall be adjusted as follows:  

    
          (a)       In
the case of any amendment to the Articles of Incorporation of the Company to
          change the rights, privileges, restrictions or conditions in respect to the
          Common Stock or division of the Common Stock, this Warrant shall be adjusted so
          as to provide that upon exercise thereof, the Holder shall receive, in lieu of
          each Common Stock theretofore issuable upon such exercise, the kind and amount
          of shares, other securities, money and property receivable upon such change or
          division by the Holder issuable upon such exercise had the exercise occurred
          immediately prior to such designation, change or division. This Warrant shall
be           deemed thereafter to provide for adjustments which shall be as nearly
equivalent           as may be practicable to the adjustments provided for in this
Section 11. The           provisions of this Section 11(a) shall apply in the same manner
to successive           reclassifications, changes, consolidations and mergers.  

    
          (b)       If
the Company shall at any time subdivide its outstanding shares of Common           Stock
into a greater number of shares of Common Stock, or declare a dividend or           make
any other distribution upon the Common Stock payable in shares of Common           Stock,
the Exercise Price in effect immediately prior to such subdivision or           dividend
or other distribution shall be proportionately reduced, and conversely,           in case
the outstanding shares of Common Stock shall be combined into a smaller           number
of shares of Common Stock, the Exercise Price in effect immediately prior           to
such combination shall be proportionately increased.  

5 

    
          (c)       If
the Company shall (i) pay a dividend in shares of Common Stock or make a
          distribution in shares of Common Stock to holders of its outstanding Common
          Stock, (ii) subdivide its outstanding shares of Common Stock into a greater
          number of shares, (iii) combine its outstanding shares of Common Stock into a
          smaller number of shares of Common Stock, or (iv) issue any shares of its
          capital stock in a reclassification of the Common Stock, then the number of
          Warrant Shares purchasable upon exercise of this Warrant immediately prior
          thereto shall be adjusted so that the Holder shall be entitled to receive the
          kind and number of Warrant Shares or other securities of the Company which it
          would have owned or have been entitled to receive had such Warrant been
          exercised in advance thereof.  

        
          No
fractional shares of Common Stock shall be issued in connection with any exercise of this
Warrant, but in lieu of such fractional shares, the Company shall make a cash payment
therefor equal in amount to the product of the applicable fraction multiplied by the
Exercise Price then in effect. 

    12.           Reorganization,
Reclassification, Merger, Consolidation or Disposition of           Assets. In case
the Company shall reorganize its capital, reclassify its           capital stock,
consolidate or merge with or into another corporation (where the           Company is not
the surviving corporation or where there is a change in or           distribution with
respect to the Common Stock of the Company), or sell, transfer           or otherwise
dispose of all or substantially all of its property, assets or           business to
another corporation and, pursuant to the terms of such           reorganization,
reclassification, merger, consolidation or disposition of           assets, shares of
common stock of the successor or acquiring corporation, or any           cash, shares of
stock or other securities or property of any nature whatsoever           (including
warrants or other subscription or purchase rights) in addition to or           in lieu of
common stock of the successor or acquiring corporation           (“Other Property”),
are to be received by or distributed to the           holders of Common Stock of the
Company, then the Holder shall have the right           thereafter to receive upon
exercise of this Warrant, the number of shares of           Common Stock of the successor
or acquiring corporation or of the Company, if it           is the surviving corporation,
and Other Property receivable upon or as a result           of such reorganization,
reclassification, merger, consolidation or disposition           of assets by a Holder of
the number of shares of Common Stock for which this           Warrant is exercisable
immediately prior to such event, and, in any such case,           appropriate provisions
shall be made with respect to the rights and interests of           the Holder to the end
that the provisions hereof (including, without limitation,           provisions for
adjustments of the Exercise Price and of the number of Warrant           Shares) shall
thereafter be applicable, as nearly as may be, in relation to any           shares of
stock, securities, other evidence of equity ownership or assets           thereafter
deliverable upon the exercise hereof (including an immediate           adjustment, by
reason of such reorganization, reclassification, merger,           consolidation or
disposition of assets, of the Exercise Price to the value for           the Common Stock
reflected by the terms of such reorganization,           reclassification, merger,
consolidation or disposition of assets if the value so           reflected is less than
the Exercise Price in effect immediately prior to such           reorganization,
reclassification, merger, consolidation or disposition of           assets). Subject to
the terms of this Warrant, in the event of a reorganization,           reclassification,
merger or consolidation of the Company with or into another           corporation or
other entity as a result of which the number of shares of common           stock of the
surviving corporation or other entity issuable to holders of Common           Stock of
the Company is greater or lesser than the number of shares of Common           Stock of
the Company outstanding immediately prior to such reorganization,
          reclassification, merger or consolidation, then the Exercise Price in effect
          immediately prior to such reorganization, reclassification, merger or
          consolidation shall be adjusted in the same manner as though there were a
          subdivision or combination of the outstanding shares of Common Stock of the
          Company. The Company shall not effect any such reorganization,
reclassification,           merger, consolidation or disposition of assets, unless, prior
to the           consummation thereof, the successor corporation (if other than the
Company)           resulting from such reorganization, reclassification, merger or
consolidation or           the corporation purchasing such assets shall assume, by
written instrument           executed and mailed or delivered to the Holder, the
obligation to deliver to the           Holder such shares of stock, securities, other
evidence of equity ownership or           assets as, in accordance with the foregoing
provisions, the Holder may be           entitled to receive or otherwise acquire. If a
purchase, tender or exchange           offer is made to and accepted by the holders of
more than fifty percent (50%) of           the outstanding shares of Common Stock of the
Company, the Company shall not           effect any reorganization, reclassification,
merger, consolidation or           disposition of assets with the person having made such
offer or with any           affiliate of such person, unless prior to the consummation of
such           reorganization, reclassification, merger, consolidation or disposition of
          assets, the Holder shall have been given a reasonable opportunity to then elect
          to receive upon the exercise of this Warrant the amount of stock, securities,
          other evidence of equity ownership or assets then issuable with respect to the
          number of shares of Common Stock in accordance with such offer. The foregoing
          provisions of this Section 12 shall similarly apply to successive
          reorganizations, reclassifications, mergers, consolidations or disposition of
          assets.  

6 

    13.           Notice
of Adjustment. Whenever the number of Warrant Shares or number or           kind of
securities or other property purchasable upon the exercise of this           Warrant or
the Exercise Price is adjusted, as herein provided, the Company shall           give
notice thereof to the Holder, which notice shall state the number of           Warrant
Shares (and other securities or property) purchasable upon the exercise           of this
Warrant and the Exercise Price of such Warrant Shares (and other           securities or
property) after such adjustment, setting forth a brief statement           of the facts
requiring such adjustment and setting forth the computation by           which such
adjustment was made.  

    14.           Notice
of Corporate Action. If at any time:  

    
          (a)                             the
Company shall take a record of the holders of its Common Stock for the
               purpose of entitling them to receive a dividend or other distribution, or
any                right to subscribe for or purchase any evidences of its indebtedness,
any shares                of stock of any class or any other securities or property, or
to receive any                other right, or  

    
          (b)                             there
shall be any capital reorganization of the Company, any reclassification
               or recapitalization of the capital stock of the Company or any
consolidation or                merger of the Company with, or any sale, transfer or
other disposition of all or                substantially all the property, assets or
business of the Company to, another                corporation, or  

    
          (c)                             there
shall be a voluntary or involuntary dissolution, liquidation or winding up
               of the Company;  

then, in any one or more of such
cases, the Company shall give to Holder (i) at least 20 calendar days’ prior written
notice of the date on which a record date shall be selected for such dividend,
distribution or right or for determining rights to vote in respect of any such
reorganization, reclassification, merger, consolidation, sale, transfer, disposition,
liquidation or winding up, and (ii) in the case of any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition, dissolution,
liquidation or winding up, at least 20 calendar days’ prior written notice of the
date when the same shall take place. Such notice in accordance with the foregoing clause
also shall specify (i) the date on which any such record is to be taken for the purpose of
such dividend, distribution or right, the date on which the holders of Common Stock shall
be entitled to any such dividend, distribution or right, and the amount and character
thereof, and (ii) the date on which any such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, dissolution, liquidation or winding up is to
take place and the time, if any such time is to be fixed, as of which the holders of
Common Stock shall be entitled to exchange their Warrant Shares for securities or other
property deliverable upon such disposition, dissolution, liquidation or winding up. Each
such written notice shall be sufficiently given if addressed to Holder at the last address
of Holder appearing on the books of the Company and delivered in accordance with Section
18(d). 

7 

    15.           Authorized
Shares. The Company covenants that, during the period the           Warrant is
outstanding, it will reserve from its authorized and unissued Common           Stock a
sufficient number of shares to provide for the issuance or transfer of           the
Warrant Shares upon the exercise of any purchase rights under this Warrant           and
will procure at its expense upon such reservation of shares the listing           thereof
(subject to issuance or notice of issuance) on all stock exchanges on           which the
Common Stock is then listed or inter-dealer trading systems on which           the Common
Stock is then traded. The Company further covenants that its issuance           of this
Warrant shall constitute full authority to its officers who are charged           with
the duty of executing stock certificates to execute and issue the necessary
          certificates for the Warrant Shares upon the exercise of the purchase rights
          under this Warrant. The Company will take all such reasonable action as may be
          necessary to assure that such Warrant Shares may be issued as provided herein
          without violation of any applicable law or regulation, or of any requirements
of           the Trading Market upon which the Common Stock may be listed or inter-dealer
          trading systems on which the Common Stock is then traded.  

        
          Except
and to the extent as waived or  consented  to by the Holder,  the  Company  shall not by
any action, including, without limitation, amending its certificate of incorporation or
through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the
observance or performance of any of the terms of this Warrant, but will at all times in
good faith assist in the carrying out of all such terms and in the taking of all such
actions as may be necessary or appropriate to protect the rights of Holder as set forth
in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (a) not increase the par value of any Warrant Shares above the amount
payable therefor upon such exercise immediately prior to such increase in par value, (b)
take all such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise
of this Warrant, and (c) use commercially reasonable efforts to obtain all such
authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof as may be necessary to enable the Company to perform its obligations
under this Warrant.  

        
          Before
taking any action which would result in an adjustment in the number of Warrant Shares for
which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all
such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.  

    16.           Registration
Rights. The Warrant Shares shall be entitled to the           registration rights as
follows. On or before October 11, 2007, the Company shall           file a registration
statement with the U.S. Securities and Exchange Commission           which includes the
Warrant Shares and identifies the Holder as a Selling           Security Holder
permitting the Holder to effectuate public resale of the Warrant           Shares as and
when determined by the Holder. The Company will use its best           efforts to have
the Registration Statement become effective, and to keep such           Registration
Statement effective for a period of at least one year following the           Effective
Date thereof or until all of the selling securities holders named           therein have
completed the distribution described in the registration statement           relating
thereto, whichever first occurs. All expenses incurred in connection           with the
above registration statement shall be borne by the Company except the           Company
shall not be required to pay fees of legal counsel of the Holder acting           on
behalf of the Holder as a selling securities holder.  

8 

    17.       Timely
Reports. The Company agrees to use its best efforts to file timely           all
reports required to be filed pursuant to Sections 13 or 15 of the Securities
          Exchange Act of 1934, as amended, and to provide such information as will
permit           the Holder to sell this Warrant or any Warrant Shares in accordance with
Rule           144 under the Securities Act.  

    18.       Miscellaneous. 

    
          (a)       Jurisdiction.
This Warant shall be construed and enforced in accordance           with the laws of the
State of New York, without giving effect to any choice of           law or conflict of
law provision or rule (whether of the State of New York or           any other
jurisdictions) that would cause the application of the laws of any
          jurisdictions other than the State of New York. The Company hereby irrevocably
          submits to the exclusive jurisdiction of the state and federal courts sitting
in           The City of New York, Borough of Manhattan, for the adjudication of any
dispute           regarding this Warrant or the Warrant Shares and hereby irrevocably
waives, and           agrees not to assert in any proceeding, any claim that it is not
personally           subject to the jurisdiction of any such court, that such proceeding
is brought           in an inconvenient forum or that the venue of such proceeding is
improper.           Nothing contained herein shall be deemed to limit in any way any
right to serve           process in any manner permitted by law. Nothing contained herein
shall be deemed           or operate to preclude the Holder from bringing suit or taking
other legal           action against the Company in any other jurisdiction with regard to
the           Company’s obligations to the Holder or to enforce a judgment or other
court           ruling in favor of the Holder. THE COMPANY HEREBY IRREVOCABLY WAIVES
ANY           RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
          ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING
          OUT OF THIS NOTE OR ANY TRANSACTION CONTEMPLATED HEREBY. 

    
          (b)       Restrictions.
The Holder acknowledges that the Warrant Shares acquired           upon the exercise of
this Warrant, if not registered, will have restrictions           upon resale imposed by
state and Federal securities laws.  

    
          (c)       Nonwaiver
and Expenses. No course of dealing or any delay or failure to           exercise any
right hereunder on the part of Holder shall operate as a waiver of           such right
or otherwise prejudice Holder’s rights, powers or remedies,
          notwithstanding all rights hereunder terminate on the Termination Date. If the
          Company willfully and knowingly fails to comply with any provision of this
          Warrant, which results in any material damages to the Holder, the Company shall
          pay to Holder such amounts as shall be sufficient to cover any costs and
          expenses including, but not limited to, reasonable attorneys’ fees,
          including those of appellate proceedings, incurred by Holder in collecting any
          amounts due pursuant hereto or in otherwise enforcing any of its rights, powers
          or remedies hereunder.  

9 

    
          (d)       Notices.
Any notice, request or other document required or permitted to           be given or
delivered to the Holder by the Company shall be delivered as           follows:  

If to the Company:

                                               Amish Naturals, Inc.

                                               8224 County Road 245

                                               Holmesville, OH 44633 

Telephone: (330)
677-0998                                             
 Facsimile: (330) 279 2415 

Attention: David
Skinner, Sr., President 

With a copy to:

                                              Dennis Brovarone, Esq.

                                                  Attorney at Law

                                             18 Mountain Laurel Drive

                                             Littleton, Colorado 80127 

Telephone: (303)
466-4092                                              
Facsimile: (303) 466-4826 

If to Wharton Capital
Partners, Ltd.                                        
   444 Madison Avenue, 40th Floor

                                                New York, NY 10022 

Telephone: (212) 765
6777                                             
 Facsimile: (212) 7657054 

    
          (e)       Limitation
of Liability. No provision hereof, in the absence of any           affirmative action
by Holder to exercise this Warrant or purchase Warrant           Shares, and no
enumeration herein of the rights or privileges of Holder, shall           give rise to
any liability of Holder for the purchase price of any Common Stock           or as a
stockholder of the Company, whether such liability is asserted by the           Company
or by creditors of the Company.  

    
          (f)       Remedies.
Holder, in addition to being entitled to exercise all rights           granted by law,
including recovery of damages, will be entitled to specific           performance of its
rights under this Warrant. The Company agrees that monetary           damages would not
be adequate compensation for any loss incurred by reason of a           breach by it of
the provisions of this Warrant and hereby agrees to waive the           defense in any
action for specific performance that a remedy at law would be           adequate.  

    
          (g)       Successors
and Assigns. Subject to applicable securities laws, this           Warrant and the
rights and obligations evidenced hereby shall inure to the           benefit of and be
binding upon the successors of the Company and the successors           and permitted
assigns of Holder. The provisions of this Warrant are intended to           be for the
benefit of all Holders from time to time of this Warrant and shall be
          enforceable by any such Holder or holder of Warrant Shares.  

10 

    
          (h)       Amendment.
This Warrant may be modified or amended or the provisions           hereof waived with
the written consent of the Company and the Holder.  

    
          (i)       Severability.
Wherever possible, each provision of this Warrant shall be           interpreted in such
manner as to be effective and valid under applicable law,           but if any provision
of this Warrant shall be prohibited by or invalid under           applicable law, such
provision shall be ineffective to the extent of such           prohibition or invalidity,
without invalidating the remainder of such provisions           or the remaining
provisions of this Warrant.  

    
          (j)       Headings.
The headings used in this Warrant are for the convenience of           reference only and
shall not, for any purpose, be deemed a part of this Warrant.  

        IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer
thereunto duly authorized. 

Dated:  February __, 2008 

		
		Amish Naturals, Inc.

By: /s/ David C. Skinner

      Name: David C. Skinner

      Title: PRESIDENT
 

11 

NOTICE OF EXERCISE 

To:    Amish Naturals, Inc. 

    (1)   The undersigned
hereby elects to purchase ________ Warrant Shares of Amish Naturals, Inc., pursuant to
the terms of the attached Warrant, and tenders herewith payment of the applicable
exercise price in full, together with all applicable transfer taxes, if any.  

    (2)   Payment shall
take the form of (check applicable box):  

[    ] Banks Draft in
lawful money of the United States; or 

[   ] Wire Transfer in
lawful money of the United States 

    (3)   Please issue
a certificate or certificates representing said Warrant Shares in the name of the
undersigned or in such other name as is specified below:  

The Warrant Shares shall be delivered
to the following: 

        (4)   Accredited
Investor. The undersigned is an “accredited investor” as defined in
Regulation D promulgated under the Securities Act of 1933, as amended. 

		
		[PURCHASER]

By: ______________________________

      Name:

      Title:

Dated:  ________________________

ASSIGNMENT FORM 

(To assign the
foregoing warrant, execute 
this form and supply required information.
 Do not use this
form to exercise the warrant.)  

        FOR
VALUE RECEIVED,  the foregoing  Warrant and all rights evidenced  thereby are hereby
assigned to  

_______________________________________________
whose address is 

_______________________________________________________________. 

_______________________________________________________________ 

		
		Dated:  ______________, _______

Holder's Signature: _____________________________

Holder's Address:   _____________________________

  

     
                 
         _____________________________

Signature Guaranteed:
 ___________________________________________ 

NOTE: The signature to this
Assignment Form must correspond with the name as it appears on the face of the Warrant,
without alteration or enlargement or any change whatsoever, and must be guaranteed by a
bank or trust company. Officers of corporations and those acting in a fiduciary or other
representative capacity should file proper evidence of authority to assign the foregoing
Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]